JPH0318634B2 - - Google Patents
Info
- Publication number
- JPH0318634B2 JPH0318634B2 JP15409082A JP15409082A JPH0318634B2 JP H0318634 B2 JPH0318634 B2 JP H0318634B2 JP 15409082 A JP15409082 A JP 15409082A JP 15409082 A JP15409082 A JP 15409082A JP H0318634 B2 JPH0318634 B2 JP H0318634B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- dimethyl
- reaction
- nitrophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 2-tetrahydropyranyloxy group Chemical group 0.000 claims description 31
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical group C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 6
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 125000005606 carbostyryl group Chemical group 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 description 94
- 238000006243 chemical reaction Methods 0.000 description 50
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 28
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 17
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 239000003054 catalyst Substances 0.000 description 12
- 239000013078 crystal Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 11
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000004220 aggregation Methods 0.000 description 7
- 230000002776 aggregation Effects 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 6
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 6
- 150000002170 ethers Chemical class 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000008096 xylene Substances 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 5
- 150000007514 bases Chemical class 0.000 description 5
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 239000007903 gelatin capsule Substances 0.000 description 5
- 150000002576 ketones Chemical class 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 150000007530 organic bases Chemical class 0.000 description 5
- 239000002798 polar solvent Substances 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 235000011181 potassium carbonates Nutrition 0.000 description 5
- 238000001953 recrystallisation Methods 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 150000001735 carboxylic acids Chemical class 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000005886 esterification reaction Methods 0.000 description 4
- 150000008282 halocarbons Chemical class 0.000 description 4
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 235000019260 propionic acid Nutrition 0.000 description 4
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229910015900 BF3 Inorganic materials 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 150000007529 inorganic bases Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 235000011118 potassium hydroxide Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 2
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 229940030600 antihypertensive agent Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000000700 radioactive tracer Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 1
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 1
- JAEUQHNZRROYID-UHFFFAOYSA-N 2-chloroethyl 3-oxobutanoate Chemical compound CC(=O)CC(=O)OCCCl JAEUQHNZRROYID-UHFFFAOYSA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- CMWKITSNTDAEDT-UHFFFAOYSA-N 2-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1C=O CMWKITSNTDAEDT-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ZETIVVHRRQLWFW-UHFFFAOYSA-N 3-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC(C=O)=C1 ZETIVVHRRQLWFW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 206010005746 Blood pressure fluctuation Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940095564 anhydrous calcium sulfate Drugs 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012059 conventional drug carrier Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 210000003748 coronary sinus Anatomy 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000006704 dehydrohalogenation reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000005290 ethynyloxy group Chemical group C(#C)O* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910001511 metal iodide Inorganic materials 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- XKORCTIIRYKLLG-ARJAWSKDSA-N methyl (z)-3-aminobut-2-enoate Chemical compound COC(=O)\C=C(\C)N XKORCTIIRYKLLG-ARJAWSKDSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 239000008023 pharmaceutical filler Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical class [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000005247 right atrial appendage Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
æ¬çºæã¯æ°èŠãªã«ã«ãã¹ããªã«èªå°äœã«é¢ã
ãã æ¬çºæã®ã«ã«ãã¹ããªã«èªå°äœã¯ãæç®æªèŒã®
æ°èŠååç©ã§ãããäžèšäžè¬åŒ(1)ã§è¡šããããã ãåŒäžïŒ²ã¯æ°ŽçŽ åååã¯äžèšåº ã瀺ããäžèšåºã«ãããŠR3ïŒR4åã³R5ã¯äœçŽã¢
ã«ãã«åºããã¯äœçŽã¢ã«ãã¬ã³åºã瀺ããR1
ã¯æ°ŽçŽ ååãæ°Žé žåºãäœçŽã¢ã«ã³ãã·åºãäœçŽã¢
ã«ã±ãã«ãªãã·åºãäœçŽã¢ã«ããã«ãªãã·åºãïŒ
âããã©ããããã©ãã«ãªãã·åºåã¯äžèšåº ïŒåºäžR3ïŒR4ïŒR5åã³ïŒ¡ã¯åèšã«åãïŒ ã瀺ããR2ã¯æ°ŽçŽ ååãäœçŽã¢ã«ãã«åºåã¯äž
èšåº ïŒåºäžR3ïŒR4ïŒR5åã³ïŒ¡ã¯åèšã«åãïŒ ã瀺ããäœãïŒR1åã³R2ã®ãã¡å¿ ããäžã€ã®
ã¿ãäžèšåº ã瀺ããã®ãšãããã«ã«ãã¹ããªã«éªšæ Œã®ïŒäœå
ã³ïŒäœã®ççŽ éçµåã¯äžéçµååã¯äºéçµåã瀺
ããã äžèšäžè¬åŒ(1)ã§è¡šããããã«ã«ãã¹ããªã«èªå°
äœã¯ãåªããè¡å°æ¿åéæå¶äœçšãã«ã«ã·ãŠã æ®
æäœäœçšïŒCaâAntagonistïŒãéå§äœçšåã³ãã¹
ããžãšã¹ãã©ãŒãŒé»å®³äœçšãæããäŸãã°è¡æ ç
ã®äºé²ä¹è³æ²»çå€ãå è¡ç®¡æ¡åŒµå€çã®å 埪ç°æ¹å
å€ãéå§å€ããã¹ããžãšã¹ãã©ãŒãŒé»å®³å€çãšã
ãŠæçšã§ãããç¹ã«æ¬çºæååç©ã¯ãäŸãã°çå¿
çåã³å¿çæ¢å¡çã®è¡å°æ¿åéèœã亢é²ããŠãã
å¿çŸæ£ã®äºé²ä¹è³æ²»çå€åã³éå§å€ãšããŠæ®ã«æ
çšã§ããã æ¬æ现æžã«ãããŠãäœçŽã¢ã«ãã«åºãšããŠã¯ã
äŸãã°ã¡ãã«ããšãã«ããããã«ãã€ãœããã
ã«ãããã«ãtertâããã«ããã³ãã«ãããã·ã«
åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ãã«åºãæããããšã
ã§ããã äœçŽã¢ã«ã³ãã·åºãšããŠã¯ãäŸãã°ã¡ããã·ã
ãšããã·ãããããã·ãã€ãœããããã·ãããã
ã·ãttertâãããã·ããã³ãã«ãªãã·ãããã·
ã«ãªãã·åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºãæ
ããããšãã§ããã äœçŽã¢ã«ã±ãã«ãªãã·åºãšããŠã¯ãäŸãã°ãã
ã«ãªãã·ãã¢ãªã«ãªãã·ãïŒâãããã«ãªãã·ã
ïŒâãããã«ãªãã·ãïŒâã¡ãã«ã¢ãªã«ãªãã·ã
ïŒâãã³ããã«ãªãã·ãïŒâããã»ãã«ãªãã·åº
çã®ççŽ æ°ïŒãïŒã®ã¢ã«ã±ãã«ãªãã·åºãæãã
ããšãã§ããã äœçŽã¢ã«ããã«ãªãã·åºãšããŠã¯ãäŸãã°ãšã
ãã«ãªãã·ãïŒâããããã«ãªãã·ãïŒâããã
ã«ãªãã·ãïŒâãããã«ãªãã·ãïŒâã¡ãã«âïŒ
âããããã«ãªãã·ãïŒâãã³ããã«ãªãã·ãïŒ
âããã·ãã«ãªãã·åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ã
ãã«ãªãã·åºãæããããšãã§ããã äœçŽã¢ã«ãã¬ã³åºãšããŠã¯ãäŸãã°ã¡ãã¬ã³ã
ãšãã¬ã³ãã¡ãã«ã¡ãã¬ã³ãããªã¡ãã¬ã³ãïŒâ
ã¡ãã«ããªã¡ãã¬ã³ãïŒïŒïŒâãžã¡ãã«ããªã¡ã
ã¬ã³ãããã©ã¡ãã¬ã³ããã³ã¿ã¡ãã¬ã³ããããµ
ã¡ãã¬ã³ãïŒâãšãã«ããªã¡ãã¬ã³ãïŒâã¡ãã«
ããªã¡ãã¬ã³åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ãã¬ã³åº
ãæããããšãã§ããã æ¬çºæã®ååç©ã¯åçš®æ¹æ³ã§è£œé ã§ããããã
ã®å¥œãŸããäžäŸã瀺ãã°äŸãã°ä»¥äžã«ç€ºãæ¹æ³ã§
補é ã§ããã ãåŒäžãR1ïŒR3ïŒR4ïŒR5ãåã³ã«ã«ãã¹ã
ãªã«éªšæ Œã®ïŒäœãšïŒäœãšã®ççŽ éçµåã¯åèšã«å
ããR1â²ã¯æ°ŽçŽ ååãæ°Žé žåºãäœçŽã¢ã«ã³ãã·åºã
äœçŽã¢ã«ã±ãã«ãªãã·åºãäœçŽã¢ã«ããã«ãªãã·
åºåã¯ïŒâããã©ããããã©ãã«ãªãã·åºã瀺
ããR2â²ã¯æ°ŽçŽ åååã¯äœçŽã¢ã«ãã«åºã瀺ãã
ã¯ããã²ã³ååã瀺ããã å³ã¡äžè¬åŒ(2)ã§è¡šããããããããã·ã«ã«ãã¹
ããªã«èªå°äœã«äžè¬åŒ(3)ã§è¡šããããååç©ãè±
ããã²ã³åæ°ŽçŽ åå¿ã®æ¡ä»¶äžã«åå¿ãããããšã«
ããæ¬çºæååç©ãååŸãããããã®çŽããã²ã³
åæ°ŽçŽ åå¿ã¯å¡©åºæ§ååç©ãè±ããã²ã³åæ°ŽçŽ å€
ãšããŠçšããŠè¡ããããå¡©åºæ§ååç©ãšããŠã¯å ¬
ç¥ã®ãã®ãåºã䜿çšã§ããããšãã°ãæ°Žé žåãã
ãªãŠã ãæ°Žé žåã«ãªãŠã ãçé žãããªãŠã ãçé ž
ã«ãªãŠã ãçé žæ°ŽçŽ ãããªãŠã ãçé žæ°ŽçŽ ã«ãªãŠ
ã ãçé žéãªã©ã®ç¡æ©å¡©åºããããªãŠã ã¡ãã©ãŒ
ãããããªãŠã ãšãã©ãŒããªã©ã®ã¢ã«ã³ã©ãŒãã
ããªãšãã«ã¢ãã³ãããªãžã³ãïŒïŒ®âãžã¡ãã«
ã¢ããªã³ãªã©ã®ææ©å¡©åºãæããããã該åå¿ã¯
溶åªã®ååšäžã«æå©ã«å®æœã§ãã溶åªãšããŠã¯å
å¿ã«æªåœ±é¿ãäžããªãäžæŽ»æ§ã®ãã®ããã¹ãŠçšã
ãããããšãã°ã¡ã¿ããŒã«ããšã¿ããŒã«ãããã
ããŒã«ããã¿ããŒã«ããšãã¬ã³ã°ãªã³ãŒã«ãªã©ã®
ã¢ã«ã³ãŒã«é¡ããžã¡ãã«ãšãŒãã«ãããã©ããã
ãã©ã³ããžãªããµã³ãã¢ãã°ã©ã€ã ããžã°ã©ã€ã
ãªã©ã®ãšãŒãã«é¡ãã¢ã»ãã³ãã¡ãã«ãšãã«ã±ã
ã³ãªã©ã®ã±ãã³é¡ããã³ãŒã³ããã«ãšã³ããã·ã¬
ã³ãªã©ã®è³éŠæçåæ°ŽçŽ é¡ãé ¢é žã¡ãã«ãé ¢é žãš
ãã«ãªã©ã®ãšã¹ãã«é¡ãïŒïŒ®âãžã¡ãã«ãã«ã
ã¢ããããžã¡ãã«ã¹ã«ãããµã€ãããããµã¡ãã«
ãªã³é žããªã¢ãããªã©ã®éãããã³æ§æ¥µæ§æº¶åªãª
ã©ãæããããããŸã該åå¿ã¯æ²åãããªãŠã ã
æ²åã«ãªãŠã ãªã©ã®éå±æ²åç©ã®ååšäžã«è¡ãªã
ããšãã§ãããäžèšæ¹æ³ã«ãããååç©(2)ã«å¯Ÿã
ãååç©(3)ã®äœ¿çšå²åã¯ãšãã«éå®ããããåºã
ç¯å²ã®äžããé©å®ã«éžæãããããéåžžåè ã«å¯Ÿ
ããŠåŸè ãçã¢ã«ãïŒåã¢ã«ã奜ãŸããã¯çã¢ã«
ãïŒåã¢ã«éã«ãŠçšããã®ãæãŸããããŸããã
ã®åå¿æž©åºŠãç¹ã«éå®ãããªãããéåžžã宀枩ã
200âã奜ãŸããã¯50ã160âã§è¡ãªããããåå¿
æéã¯éåžžïŒã30æéã奜ãŸããã¯ïŒã10æéã§
ãããæ¯ãããŠäžè¬åŒ(1)ã§è¡šããããååç©äžïŒ²
ãåº ã瀺ãååç©ïŒäžè¬åŒïŒ1aïŒã®ååç©ïŒãååŸ
ã§ããã äžè¬åŒ(1)ã§è¡šããããååç©äžR1åã¯R2ãåº ã瀺ãååç©ã亊ãã察å¿ããäžè¬åŒ(2)ã§è¡šãã
ããååç©åæãšããŠãåæ§ã«äžèšåå¿è¡çšåŒâ
ïŒã«åŸã補é ã§ããã ãåŒäžãR1â²ïŒR2â²ïŒR3ïŒR4ïŒR5ïŒïŒ¡ïŒïŒžåã³
ã«ã«ãã¹ããªã«éªšæ Œã®ïŒäœãšïŒäœãšã®ççŽ éçµå
ã¯åèšã«åããã äžèšåå¿è¡çšåŒâïŒã«ãããŠããããã·ã«ã«ã
ã¹ããªã«èªå°äœ(2)ãšååç©(4)ãšã®åå¿ã«ãããŠ
ã¯ãåèšåå¿è¡çšåŒâïŒã«ãããååç©(2)ãšåå
ç©(3)ãšã®åå¿ãšåæ§ã®åå¿æ¡ä»¶ãæ¡çšã§ããã ååç©(5)ãšååç©(6)ãšã®åå¿ã«ãããŠã¯ãéåžž
ã®ãšã¹ãã«ååå¿ã®æ¡ä»¶ãæ¡çšãããšãã§ããã
該åå¿ã¯ãé垞觊åªã®ååšäžã§è¡ãªããããã®é
䜿çšããã觊åªãšããŠã¯ãéåžžã®ãšã¹ãã«ååå¿
ã«äœ¿çšãããŠãããã®ãåºã䜿çšããåŸãã代衚
çãªãã®ãšããŠã¯ãäŸãã°å¡©é žã¬ã¹ãæ¿ç¡«é žããª
ã³é žãããªãªã³é žãäžåŒåç¡ŒçŽ ãéå¡©çŽ é žãªã©ã®
ç¡æ©é žãããªãããé ¢é žãããªãããã¡ã¿ã³ã¹ã«
ãã³é žãããã¿ã¬ã³ã¹ã«ãã³é žãïœâãã·ã«é žã
ãã³ãŒã³ã¹ã«ãã³é žããšã¿ã³ã¹ã«ãã³é žãªã©ã®æ
æ©é žãããªãããã¡ã¿ã³ã¹ã«ãã³é žç¡æ°Žç©ãå¡©å
ããªãã«ãã¢ã»ãã³ãžã¡ãã«ã¢ã»ã¿ãŒã«ãªã©ãäŸ
瀺ã§ãããããã«é žæ§ã€ãªã³äº€ææš¹èã該觊åªãš
ããŠçšããããšãã§ããããããã®è§Šåªã®äœ¿çšé
ã¯ç¹ã«éå®ããããéåžžã®ãšã¹ãã«ååå¿ã«çšã
ãããç¯å²ã§äœ¿çšããããäžèšåå¿ã¯ç¡æº¶åªãã
ãã¯æº¶åªäžã®ãããã§ãé²è¡ããããã®é䜿çšã
ãã溶åªãšããŠã¯ãéåžžã®ãšã¹ãã«ååå¿ã«äœ¿çš
ããã溶åªãæå¹ã«äœ¿çšã§ããå ·äœçã«ã¯ãã³ãŒ
ã³ããã«ãšã³ããã·ã¬ã³ãªã©ã®è³éŠæçåæ°ŽçŽ
é¡ããžã¯ããã¡ã¿ã³ããžã¯ãããšã¿ã³ãã¯ããã
ã«ã ãåå¡©åççŽ ãªã©ã®ããã²ã³åçåæ°ŽçŽ é¡ã
ãžãšãã«ãšãŒãã«ãããã©ããããã©ã³ããžãªã
ãµã³ããšãã¬ã³ã°ãªã³ãŒã«ã¢ãã¡ãã«ãšãŒãã«ãª
ã©ã®ãšãŒãã«é¡ãªã©ãæãããããäžèšã®åå¿ã«
ãããŠã¯ãååç©(5)ãšååç©(6)ãšã®äœ¿çšå²åã¯åº
ãç¯å²ã«ãããé©å®ã«éžæããã°ããããæ¬çºæ
ã®ç®çç©ã®çæçãè¯å¥œã«ããããã«éåžžç¡æº¶åª
ã®å Žåã«ã¯åè ã«å¯ŸãåŸè ã倧éå°éçšãããŸã
溶åªãçšããå Žåã«ã¯åè ã«å¯ŸãåŸè ãçã¢ã«ã
ïŒåã¢ã«ãç¹ã«å¥œãŸããã¯çã¢ã«ãïŒåã¢ã«éçš
ããã®ãããããªããäžèšåå¿ã®å®æœã«éããç¡
æ°Žå¡©åã«ã«ã·ãŠã ãç¡æ°Žç¡«é žé ãç¡æ°Žç¡«é žã«ã«ã·
ãŠã ãäºé žåãªã³ãªã©ã®ä¹Ÿç¥å€ãçšããŠçææ°Žã
åå¿ç³»ããé€å»ããããšã«ããããã«çæçãå¢
倧ãããããšãå¯èœã§ãããæ¬åå¿ã«æŒããåå¿
枩床ã¯é©å®éžæããã°ãããç¹ã«éå®ãããªã
ããéåžžçŽâ20ã200âçšåºŠã®ç¯å²ã§è¡ãªãã®ã
ãããç¹ã«çŽïŒã150âçšåºŠã§è¡ãªãã®ã奜ãŸã
ãããŸãåå¿æéã¯åæã®çš®é¡ãåå¿æ¡ä»¶ã«ãã
ãäžè¬ã«çŽ10åã20æéã§åå¿ã¯çµäºãããæ¯ã
ããŠäžè¬åŒïŒ1aïŒã®ååç©ãååŸãããã äžè¬åŒ(1)ã§è¡šããããååç©äžR1åã¯R2ãåº ã瀺ãååç©ã亊ã察å¿ããäžè¬åŒ(2)ã§è¡šããã
ãååç©ãåæãšããŠãåæ§ã«äžèšåå¿è¡çšåŒâ
ïŒã«åŸã補é ã§ããã ãåŒäžãR1â²ïŒR2â²ïŒR4ïŒR5ïŒïŒ¡åã³ã«ã«ãã¹
ããªã«éªšæ Œã®ïŒäœãšïŒäœãšã®ççŽ éçµåã¯åèšã«
åããã äžèšåå¿åŒã«ãããååç©(5)ãšååç©(7)ãšã®å
å¿ã¯ãé©åœãªæº¶åªäžè§Šåªã®ååšäžã«è¡ãªãããã
觊åªãšããŠã¯ãäŸãã°ããªãšãã«ã¢ãã³ãããªãž
ã³ãïŒïŒ®âãžã¡ãã«ã¢ããªã³çã®ææ©å¡©åºãé ¢
é žãããªãŠã ãçé žã«ãªãŠã çã®ç¡æ©å¡©åºçã®å¡©
åºæ§ååç©ãïœâãã«ãšã³ã¹ã«ãã³é žçã®ã¹ã«ã
ã³é žãäžåŒåç¡ŒçŽ çã®ã«ã€ã¹é žçã®é žæ§ååç©ç
ãæããããšãã§ããããŸã溶åªãšããŠã¯ãäŸã
ã°ãã³ãŒã³ããã«ãšã³ããã·ã¬ã³çã®è³éŠæçå
æ°ŽçŽ é¡ãé ¢é žã¡ãã«ãé ¢é žãšãã«çã®ãšã¹ãã«
é¡ãå¡©åã¡ãã¬ã³ãã¯ãããã«ã ãïŒïŒïŒâãžã¯
ãããšã¿ã³çã®ããã²ã³åçåæ°ŽçŽ é¡ããšãŒã
ã«ãããã©ããããã©ã³ããžãªããµã³ãã¢ãã°ã©
ã€ã ããžã°ã©ã€ã çã®ãšãŒãã«é¡ãã¢ã»ãã³ãã¡
ãã«ãšãã«ã±ãã³çã®ã±ãã³é¡ãïŒïŒ®âãžã¡ã
ã«ãã«ã ã¢ããããžã¡ãã«ã¹ã«ããã·ãããããµ
ã¡ãã«ãªã³é žããªã¢ãããâã¡ãã«ãããªãã³
çã®éãããã³æ§æ¥µæ§æº¶åªçãæããããšãã§ã
ããååç©(5)ãšååç©(7)ãšã®äœ¿çšå²åãšããŠã¯ã
éåžžåè ã«å¯ŸããŠåŸè ãå°ãªããšãçã¢ã«éçš
床ã奜ãŸããã¯ïŒãïŒåã¢ã«çšåºŠäœ¿çšããã°ã
ãããŸãäžèšè§Šåªã®äœ¿çšéãšããŠã¯ãç¹ã«éå®ã
ããªãããéåžžååç©(5)ã«å¯ŸããŠïŒïŒ100ã10å
ã¢ã«çšåºŠãšããã®ãããã該åå¿ã¯ãéåžžâ20ã
200âã奜ãŸããã¯â20ã100âçšåºŠã«ãŠãäžè¬ã«
10åã20æéçšåºŠã§çµäºããã 次ãã§åŸãããååç©(8)ãšååç©(9)ãšã®åå¿ã
亊ãé©åœãªæº¶åªäžè§Šåªã®ååšäžã«è¡ãªãããã該
溶åªãšããŠã¯ãäŸãã°ã¡ã¿ããŒã«ããšã¿ããŒã«ã
ãããããŒã«ããã¿ããŒã«ããšãã¬ã³ã°ãªã³ãŒã«
ãªã©ã®ã¢ã«ã³ãŒã«é¡ããšãŒãã«ãããã©ãããã
ã©ã³ããžãªããµã³ãã¢ãã°ã©ã€ã ããžã°ã©ã€ã ãª
ã©ã®ãšãŒãã«é¡ããã³ãŒã³ããã«ãšã³ããã·ã¬ã³
ãªã©ã®è³éŠæçåæ°ŽçŽ é¡ãå¡©åã¡ãã¬ã³ãã¯ãã
ãã«ã ãïŒïŒïŒâãžã¯ãããšã¿ã³ãªã©ã®ããã²ã³
åçåæ°ŽçŽ é¡ãïŒïŒ®âãžã¡ãã«ãã«ã ã¢ããã
ãžã¡ãã«ã¹ã«ããã·ãããããµã¡ãã«ãªã³é žããª
ã¢ãããªã©ã®éãããã³æ§æ¥µæ§æº¶åªãé ¢é žããã
ããªã³é žãªã©ã®ã«ã«ãã³é žé¡ãããªãžã³çãæã
ãããšãã§ãããŸã觊åªãšããŠã¯ãäŸãã°ããªãž
ã³ããããªãžã³ãããªãšãã«ã¢ãã³ããžãšãã«ã¢
ãã³ãDBUãªã©ã®ææ©å¡©åºããããªãŠã ãšãã©
ãŒãããããªãŠã ã¡ãã©ãŒããªã©ã®éå±ã¢ã«ã³ã©
ãŒãé¡ãæ°Žé žåãããªãŠã ãæ°Žé žåã«ãªãŠã ãç
é žã«ãªãŠã ãé ¢é žã«ãªãŠã ãªã©ã®ç¡æ©å¡©åºãå¡©
é žãç¡«é žãªã©ã®é±é žé¡ãé ¢é žãããããªã³é žãªã©
ã®ã«ã«ãã³é žé¡ãäžåŒåç¡ŒçŽ ãªã©ã®ã«ã€ã¹é žé¡ç
ãæãããããååç©(8)ãšååç©(9)ãšã®äœ¿çšå²å
ãšããŠã¯ãéåžžåè ã«å¯ŸããŠåŸè ãå°ããšãçã¢
ã«éã奜ãŸããã¯çã¢ã«ãïŒåã¢ã«çšåºŠäœ¿çšãã
ã°ããããŸã觊åªã®äœ¿çšéãšããŠã¯ãåèšååç©
(5)ãšååç©(7)ãšã®åå¿ã«ããã觊åªéãšåæ§ã«ã
ãã°ããã該åå¿ã¯ãéåžžâ20ã200âã奜ãŸã
ãã¯â20ã150âçšåºŠã«ãŠãäžè¬ã«10åã50æé
çšåºŠã§çµäºããã ååç©(10)ãšååç©(11)ãšã®åå¿ã¯ã溶åªã®ååšäž
ã«æå©ã«å®æœã§ããã溶åªãšããŠã¯åå¿ã«æªåœ±é¿
ãäžããªãäžæŽ»æ§ã®ãã®ããã¹ãŠçšããããäŸã
ã°ã¢ã»ãã³çã®ã±ãã³é¡ãã¯ãããã«ã çã®ãã
ã²ã³åçåæ°ŽçŽ é¡ãã¡ã¿ããŒã«ããšã¿ããŒã«ãã
ããããŒã«ããšãã¬ã³ã°ãªã³ãŒã«ãªã©ã®ã¢ã«ã³ãŒ
ã«é¡ããžãšãã«ãšãŒãã«ãããã©ããããã©ã³ã
ãžãªããµã³ãã¢ãã°ã©ã€ã ããžã°ã©ã€ã ãªã©ã®ãš
ãŒãã«é¡ããã³ãŒã³ããã«ãšã³ããã·ã¬ã³ãªã©ã®
è³éŠæçåæ°ŽçŽ é¡ãé ¢é žã¡ãã«ãé ¢é žãšãã«ãªã©
ã®ãšã¹ãã«é¡ãé ¢é žãããããªã³é žãªã©ã®ã«ã«ã
ã³é žãããªãžã³ãªã©ã®ææ©å¡©åºãïŒïŒ®âãžã¡ã
ã«ãã«ã ã¢ããããžã¡ãã«ã¹ã«ããã·ãããããµ
ã¡ãã«ãªã³é žããªã¢ãããªã©ã®éãããã³æ§æ¥µæ§
溶åªçãæãããããååç©(10)ãšååç©(11)ãšã®äœ¿
çšå²åã¯ãéåžžåè ã«å¯ŸãåŸè ãçã¢ã«ã10åã¢
ã«ã奜ãŸããã¯çã¢ã«ãïŒåã¢ã«çšåºŠäœ¿çšããã®
ãããã該åå¿ã¯ãéåžžâ20ã200âã奜ãŸãã
ã¯50ã150âçšåºŠã«ãŠãäžè¬ã«10åã20æéçšåºŠ
ã§çµäºãããæ¯ãããŠäžè¬åŒ(1)ã§è¡šããããåå
ç©äžïŒ²ãåº ã瀺ãäžã€R3ãã¡ãã«åºã瀺ãååç©ïŒäžè¬åŒ
ïŒ1bïŒã®ååç©ïŒãååŸã§ããã äžè¬åŒ(1)ã§è¡šããããååç©äžR1åã¯R2ãåº ã瀺ãäžã€R3ãã¡ãã«åºã瀺ãååç©ã亊ã察
å¿ããäžè¬åŒ(5)ã§è¡šããããååç©ãåæãšã
ãŠãåæ§ã«äžèšåå¿è¡çšåŒâïŒã«åŸã補é ã§ã
ãã ãåŒäžãR2â²ïŒR3ïŒR4.R5ïŒïŒ¡ïŒïŒžåã³ã«ã«ã
ã¹ããªã«éªšæ Œã®ïŒäœãšïŒäœã®ççŽ éçµåã¯åèšã«
åããR6ã¯äœçŽã¢ã«ãã«åºãäœçŽã¢ã«ã±ãã«åºã
äœçŽã¢ã«ããã«åºåã¯ïŒâããã©ããããã©ãã«
åºã瀺ããOTHPã¯ïŒâããã©ããããã©ãã«
ãªãã·åºã瀺ããã äžèšåå¿è¡çšåŒâïŒã«ããã°ãäžè¬åŒ(1)ã§è¡šã
ãããååç©äžïŒ²ãåº ã瀺ãäžã€R1ãïŒâããã©ããããã©ãã«ãªã
ã·åºã瀺ãååç©ïŒäžäžè¬åŒïŒ1cïŒã®ååç©ïŒã
å æ°Žå解ããããšã«ãã察å¿ããR1ãæ°Žé žåºã
瀺ãååç©ïŒäžè¬åŒïŒ1dïŒã®ååç©ïŒã«ãæŽã«
該ååç©ïŒ1dïŒã«ååç©(12)ãåå¿ããããšã«ã
ã察å¿ããR1ãäœçŽã¢ã«ã³ãã·åºãäœçŽã¢ã«ã±
ãã«ãªãã·åºãäœçŽã¢ã«ããã«ãªãã·åºåã¯ïŒâ
ããã©ããããã©ãã«ãªãã·åºã瀺ãååç©ïŒïŒ
è¬åŒïŒ1eïŒã®ååç©ïŒã«å€«ã å€æããããšãã§ã
ãã äžèšã«ãããŠãååç©ïŒ1cïŒã®å æ°Žå解ã¯ãç¡
溶åªåã¯é©åœãªæº¶åªäžé žãäœçšãããããšã«ãã
è¡ãããã溶åªãšããŠã¯ãäŸãã°æ°Žãã¡ã¿ããŒ
ã«ããšã¿ããŒã«ãã€ãœãããããŒã«çã®äœçŽã¢ã«
ã³ãŒã«é¡ããžãªããµã³ãããã©ããããã©ã³çã®
ãšãŒãã«é¡ãã¢ã»ãã³çã®ã±ãã³é¡ãé ¢é žåã³ã
ããã®æ··å溶åªçãæãããããé žãšããŠã¯ãäŸ
ãã°å¡©é žãç¡«é žçã®é±é žé¡ãïœâãã«ãšã³ã¹ã«ã
ã³é žãããªãžã³ïŒ°âãã«ãšã³ã¹ã«ãã³é žå¡©ãé ¢
é žãããããªã³é žçã®ã«ã«ãã³é žé¡çãæããã
ãšãã§ãããæ¯ããé žã®äœ¿çšéãšããŠã¯ãååç©
ïŒ1cïŒã«å¯ŸããŠå°ããšãçã¢ã«ä»¥äžãé垞倧éå°
é䜿çšããã®ããããåå¿æž©åºŠã¯ãéåžžâ20ã
200âã奜ãŸããã¯â20ã50âçšåºŠãšããã®ãã
ããäžè¬ã«0.5ãïŒæéçšåºŠã§åå¿ã¯çµäºããã ããããŠåŸãããååç©ïŒ1dïŒãšååç©(12)ãš
ã®åå¿ã¯ãéåžžã®ã¢ã«ãã«ååå¿ã®æ¡ä»¶äžã«è¡ãª
ãããäŸãã°å¡©åºæ§ååç©ã®ååšäžã«å®æœãã
ãããã®é䜿çšãããå¡©åºæ§ååç©ãšããŠã¯ãäŸ
ãã°éå±ãããªãŠã ãéå±ã«ãªãŠã çã®ã¢ã«ã«ãª
éå±é¡äžŠã³ã«ãããã¢ã«ã«ãªéå±ã®æ°Žé žåç©ãç
é žå¡©ãéçé žå¡©ãããã¯ã¢ã«ã³ã©ãŒãæãã¯ããª
ãžã³ããããªãžã³çã®è³éŠæã¢ãã³ååç©ãããª
ãšãã«ã¢ãã³ãïŒïŒïŒâãžã¢ã¶ãã·ã¯ããŠã³ãã»
ã³âïŒçã®ææ©å¡©åºçãæããããã該åå¿ã¯ã
é©åœãªæº¶åªäžã§æå©ã«é²è¡ãããã®é䜿çšããã
溶åªãšããŠã¯ãæ°Žãã¡ã¿ããŒã«ããšã¿ããŒã«ãã€
ãœãããããŒã«ãïœâãã¿ããŒã«çã®äœçŽã¢ã«ã³
ãŒã«é¡ãã¢ã»ãã³ãã¡ãã«ãšãã«ã±ãã³çã®ã±ã
ã³é¡ãã¯ãããã«ã ããžã¯ãããšã¿ã³çã®ããã²
ã³åçåæ°ŽçŽ é¡ããã³ãŒã³ããã«ãšã³ããã·ã¬ã³
çã®è³éŠæçåæ°ŽçŽ é¡ãïŒïŒ®âãžã¡ãã«ãã«ã
ã¢ããããžã¡ãã«ã¹ã«ããã·ãçã®éãããã³æ§
極æ§æº¶åªçãæãããããååç©ïŒ1dïŒãšåå
ç©(12)ãšã®äœ¿çšå²åãšããŠã¯ãéåžžåè ã«å¯ŸããŠåŸ
è ãå°ããšãçã¢ã«ä»¥äžã奜ãŸããã¯çã¢ã«ãïŒ
åã¢ã«éçšåºŠäœ¿çšããã®ãããã該åå¿æž©åºŠãšã
ãŠã¯ãäžè¬ã«â20ã200âã奜ãŸããã¯ïŒã100â
çšåºŠã§è¡ãªãããäžè¬ã«10åã20æéçšåºŠã§çµäº
ããã äžè¬åŒ(1)ã§è¡šããããååç©äžR2ãåº ã瀺ããR1ãæ°Žé žåºã瀺ãååç©ãR1ãäœçŽã¢
ã«ã³ãã·åºãäœçŽã¢ã«ã±ãã«ãªãã·åºãäœçŽã¢ã«
ããã«ãªãã·åºåã¯ïŒâããã©ããããã©ãã«ãª
ãã·åºã瀺ãååç©ã亊ã察å¿ããR1ãïŒâã
ãã©ããããã©ãã«ãªãã·åºã瀺ãååç©ããã
äžèšåå¿è¡çšåŒâïŒã«åŸãåæ§ã«å€æãããã åèšåå¿è¡çšåŒâïŒã«ãããŠãåºçºåæã§ãã
äžè¬åŒ(3)ã®ååç©ã¯ãäŸãã°äžèšåå¿è¡çšåŒâïŒ
ã«ç€ºãæ¹æ³ã«ãã容æã«è£œé ããããšãã§ããã ãåŒäžãR3ïŒR4ïŒR5ïŒïŒ¡åã³ïŒžã¯åèšã«å
ããã äžèšåå¿åŒã«ãããŠãååç©(9)ãšååç©ïŒ13ïŒ
ãšã®åå¿ã¯ãåèšåå¿è¡çšåŒâïŒã«ãããååç©
(8)ãšååç©(9)ãšã®åå¿ãšåæ§ã®åå¿æ¡ä»¶ãæ¡çšã§
ããã ãŸããååç©ïŒ14ïŒãšååç©(11)ãšã®åå¿ã¯ãå
èšåå¿è¡çšåŒâïŒã«ãããååç©(10)ãšååç©(11)ãš
ã®åå¿ãšåæ§ã®åå¿æ¡ä»¶ãæ¡çšã§ããã æ¯ãããŠåŸãããäžè¬åŒ(1)ã§è¡šããããååç©
ã®ãã¡å¡©åºæ§åºãæããååç©ã¯è¬ççã«èš±å®¹ã
åŸãé žãšå¡©ã圢æãåŸããæ¯ããé žãšããŠå ·äœç
ã«ã¯ç¡«é žãç¡é žãå¡©é žãèåæ°ŽçŽ é žçã®ç¡æ©é žç
ãäŸç€ºã§ããã æ¯ãããŠåŸãããæ¬çºæã®ååç©ã¯éåžžçšãã
ããŠããåé¢æ段ã«ãã容æã«åé¢ã粟補ãã
ããæ¯ããåé¢æ段ãšããŠã¯æ²æ®¿æ³ãæœåºæ³ãå
çµæ¶æ³ãã«ã©ã ã¯ãããã°ã©ãã€ãŒããã¬ãã©ã
ã€ãèå±€ã¯ãããã°ã©ãã€ãŒçãäŸç€ºã§ããã æ¬çºæååç©ã¯ãã®ãŸãŸã§ãããã¯æ £çšã®è£œå€
æ äœãšå ±ã«åç©åã³äººã«æäžããããšãã§ããã
æäžåäœåœ¢æ ãšããŠã¯ç¹ã«éå®ããªãå¿ èŠã«å¿ã
é©å®éžæããŠäœ¿çšããããæ¯ããæäžåäœåœ¢æ ãš
ããŠã¯é å€ãé¡ç²å€ãçµå£çšæº¶æ¶²çã®çµå£å€ã泚
å°å€çã®éçµå£å€çãäŸç€ºã§ãããæäžãããã¹
ãæå¹æåã®éãšããŠã¯ç¹ã«éå®ããªãåºãç¯å²
ããé©å®éžæãããããææã®å¹æãçºæ®ããã
ãã«ã¯ïŒæ¥åœãäœéïŒKgåœã0.06ã10mgãšããã®
ãããããŸãæäžåäœåœ¢æ äžã«æå¹æåãïŒã
500mgå«æããããã®ãããã æ¬çºæã«æŒãŠé å€ãã«ãã»ã«å€ãçµå£çšæº¶æ¶²ç
ã®çµå£å€ã¯åžžæ³ã«åŸã€ãŠè£œé ããããå³ã¡é å€ã¯
æ¬çºæååç©ããŒã©ãã³ã柱ç²ãä¹³ç³ãã¹ãã¢ãª
ã³é žãã°ãã·ãŠã ãæ»ç³ãã¢ã©ãã¢ãŽã çã®è£œå€
åŠç賊圢å€ãšæ··åãã賊圢ããããã«ãã»ã«å€ã¯
æ¬çºæååç©ãäžæŽ»æ§ã®è£œå€å å¡«å€ãããã¯åžé
å€ãšæ··åãã硬質ãŒã©ãã³ã«ãã»ã«ãè»è³ªã«ãã»
ã«çã«å å¡«ããããã·ãããå€ãããã¯ãšãªãã·
ã¢å€ã¯æ¬çºæååç©ãèç³çã®çå³å€ãã¡ãã«â
ããã³ãããã«ãã©ãã³é¡çã®é²è å€ãçè²å€ã
調å³å€çãšæ··åããŠè£œé ãããããŸãéçµå£å€ã¯
åžžæ³ã«åŸã€ãŠè£œé ããããå³ã¡éçµå£æäžçšè¬å€
ã¯æ¬çºæååç©ãæ» èãã液ç¶æ äœã«æº¶è§£ããŠè£œ
é ãããã奜ãŸããæ äœã¯æ°ŽãŸãã¯å¡©æ°Žã§ããã
ææã®éæ床ãå®å®æ§åã³éçµå£äœ¿çšã®é©å¿æ§ã
æãã液å€ã¯çŽïŒã500mgã®æå¹æåããæ°Žåã³
ææ©æº¶å€ã«æº¶è§£ãäžã€ååéã200ã5000ã§ãã
ããªãšãã¬ã³ã°ãªã³ãŒã«ã«æº¶è§£ããŠè£œé ãããã
æ¯ãã液å€ã«ã¯ãããªãŠã ã«ã«ããã·ã¡ãã«ã»ã«
ããŒãºãã¡ãã«ã»ã«ããŒããããªããã«ãããªã
ã³ãããªããã«ã¢ã«ã³ãŒã«çã®æœ€æ»å€ãå«æãã
ãŠããã®ã奜ãŸãããããã«ã¯äžèšæº¶å€äžã«ãã³
ãžã«ã¢ã«ã³ãŒã«ãããšããŒã«ããã¡ããµãŒã«çã®
殺èå€ããã³é²ã«ãå€ãããã«å¿ èŠã«å¿ãèç³ã
å¡©åãããªãŠã çã®ç匵å€ãå±æ麻é å€ãå®å®
å€ãç·©è¡å€çãå«ãŸããŠããŠããããæŽã«å®å®æ§
ãé«ããããã«éçµå£æäžçšè¬å€ã¯å å¡«åŸå·åã
ãããã®åéã§å ¬ç¥ã®åçµä¹Ÿç¥æè¡ã«ããæ°Žãé€
å»ããããšãã§ãããèããŠäœ¿çšçŽåã«åçµä¹Ÿç¥
ç²æ«ãå調補ããããšãã§ããã é å€ã®èª¿è£œ ããããïŒmgã®ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«â
ïŒâã¡ããã·ã«ã«ããã«âïŒâïŒïŒâãããããš
ãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ã
ãã·ããšããã·ïœã«ã«ãã¹ããªã«ãå«æããçµå£
䜿çšã®ããã®1000é ã次ã®åŠæ¹ã«ãã€ãŠèª¿è£œãã
ãã
ãã æ¬çºæã®ã«ã«ãã¹ããªã«èªå°äœã¯ãæç®æªèŒã®
æ°èŠååç©ã§ãããäžèšäžè¬åŒ(1)ã§è¡šããããã ãåŒäžïŒ²ã¯æ°ŽçŽ åååã¯äžèšåº ã瀺ããäžèšåºã«ãããŠR3ïŒR4åã³R5ã¯äœçŽã¢
ã«ãã«åºããã¯äœçŽã¢ã«ãã¬ã³åºã瀺ããR1
ã¯æ°ŽçŽ ååãæ°Žé žåºãäœçŽã¢ã«ã³ãã·åºãäœçŽã¢
ã«ã±ãã«ãªãã·åºãäœçŽã¢ã«ããã«ãªãã·åºãïŒ
âããã©ããããã©ãã«ãªãã·åºåã¯äžèšåº ïŒåºäžR3ïŒR4ïŒR5åã³ïŒ¡ã¯åèšã«åãïŒ ã瀺ããR2ã¯æ°ŽçŽ ååãäœçŽã¢ã«ãã«åºåã¯äž
èšåº ïŒåºäžR3ïŒR4ïŒR5åã³ïŒ¡ã¯åèšã«åãïŒ ã瀺ããäœãïŒR1åã³R2ã®ãã¡å¿ ããäžã€ã®
ã¿ãäžèšåº ã瀺ããã®ãšãããã«ã«ãã¹ããªã«éªšæ Œã®ïŒäœå
ã³ïŒäœã®ççŽ éçµåã¯äžéçµååã¯äºéçµåã瀺
ããã äžèšäžè¬åŒ(1)ã§è¡šããããã«ã«ãã¹ããªã«èªå°
äœã¯ãåªããè¡å°æ¿åéæå¶äœçšãã«ã«ã·ãŠã æ®
æäœäœçšïŒCaâAntagonistïŒãéå§äœçšåã³ãã¹
ããžãšã¹ãã©ãŒãŒé»å®³äœçšãæããäŸãã°è¡æ ç
ã®äºé²ä¹è³æ²»çå€ãå è¡ç®¡æ¡åŒµå€çã®å 埪ç°æ¹å
å€ãéå§å€ããã¹ããžãšã¹ãã©ãŒãŒé»å®³å€çãšã
ãŠæçšã§ãããç¹ã«æ¬çºæååç©ã¯ãäŸãã°çå¿
çåã³å¿çæ¢å¡çã®è¡å°æ¿åéèœã亢é²ããŠãã
å¿çŸæ£ã®äºé²ä¹è³æ²»çå€åã³éå§å€ãšããŠæ®ã«æ
çšã§ããã æ¬æ现æžã«ãããŠãäœçŽã¢ã«ãã«åºãšããŠã¯ã
äŸãã°ã¡ãã«ããšãã«ããããã«ãã€ãœããã
ã«ãããã«ãtertâããã«ããã³ãã«ãããã·ã«
åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ãã«åºãæããããšã
ã§ããã äœçŽã¢ã«ã³ãã·åºãšããŠã¯ãäŸãã°ã¡ããã·ã
ãšããã·ãããããã·ãã€ãœããããã·ãããã
ã·ãttertâãããã·ããã³ãã«ãªãã·ãããã·
ã«ãªãã·åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ã³ãã·åºãæ
ããããšãã§ããã äœçŽã¢ã«ã±ãã«ãªãã·åºãšããŠã¯ãäŸãã°ãã
ã«ãªãã·ãã¢ãªã«ãªãã·ãïŒâãããã«ãªãã·ã
ïŒâãããã«ãªãã·ãïŒâã¡ãã«ã¢ãªã«ãªãã·ã
ïŒâãã³ããã«ãªãã·ãïŒâããã»ãã«ãªãã·åº
çã®ççŽ æ°ïŒãïŒã®ã¢ã«ã±ãã«ãªãã·åºãæãã
ããšãã§ããã äœçŽã¢ã«ããã«ãªãã·åºãšããŠã¯ãäŸãã°ãšã
ãã«ãªãã·ãïŒâããããã«ãªãã·ãïŒâããã
ã«ãªãã·ãïŒâãããã«ãªãã·ãïŒâã¡ãã«âïŒ
âããããã«ãªãã·ãïŒâãã³ããã«ãªãã·ãïŒ
âããã·ãã«ãªãã·åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ã
ãã«ãªãã·åºãæããããšãã§ããã äœçŽã¢ã«ãã¬ã³åºãšããŠã¯ãäŸãã°ã¡ãã¬ã³ã
ãšãã¬ã³ãã¡ãã«ã¡ãã¬ã³ãããªã¡ãã¬ã³ãïŒâ
ã¡ãã«ããªã¡ãã¬ã³ãïŒïŒïŒâãžã¡ãã«ããªã¡ã
ã¬ã³ãããã©ã¡ãã¬ã³ããã³ã¿ã¡ãã¬ã³ããããµ
ã¡ãã¬ã³ãïŒâãšãã«ããªã¡ãã¬ã³ãïŒâã¡ãã«
ããªã¡ãã¬ã³åºçã®ççŽ æ°ïŒãïŒã®ã¢ã«ãã¬ã³åº
ãæããããšãã§ããã æ¬çºæã®ååç©ã¯åçš®æ¹æ³ã§è£œé ã§ããããã
ã®å¥œãŸããäžäŸã瀺ãã°äŸãã°ä»¥äžã«ç€ºãæ¹æ³ã§
補é ã§ããã ãåŒäžãR1ïŒR3ïŒR4ïŒR5ãåã³ã«ã«ãã¹ã
ãªã«éªšæ Œã®ïŒäœãšïŒäœãšã®ççŽ éçµåã¯åèšã«å
ããR1â²ã¯æ°ŽçŽ ååãæ°Žé žåºãäœçŽã¢ã«ã³ãã·åºã
äœçŽã¢ã«ã±ãã«ãªãã·åºãäœçŽã¢ã«ããã«ãªãã·
åºåã¯ïŒâããã©ããããã©ãã«ãªãã·åºã瀺
ããR2â²ã¯æ°ŽçŽ åååã¯äœçŽã¢ã«ãã«åºã瀺ãã
ã¯ããã²ã³ååã瀺ããã å³ã¡äžè¬åŒ(2)ã§è¡šããããããããã·ã«ã«ãã¹
ããªã«èªå°äœã«äžè¬åŒ(3)ã§è¡šããããååç©ãè±
ããã²ã³åæ°ŽçŽ åå¿ã®æ¡ä»¶äžã«åå¿ãããããšã«
ããæ¬çºæååç©ãååŸãããããã®çŽããã²ã³
åæ°ŽçŽ åå¿ã¯å¡©åºæ§ååç©ãè±ããã²ã³åæ°ŽçŽ å€
ãšããŠçšããŠè¡ããããå¡©åºæ§ååç©ãšããŠã¯å ¬
ç¥ã®ãã®ãåºã䜿çšã§ããããšãã°ãæ°Žé žåãã
ãªãŠã ãæ°Žé žåã«ãªãŠã ãçé žãããªãŠã ãçé ž
ã«ãªãŠã ãçé žæ°ŽçŽ ãããªãŠã ãçé žæ°ŽçŽ ã«ãªãŠ
ã ãçé žéãªã©ã®ç¡æ©å¡©åºããããªãŠã ã¡ãã©ãŒ
ãããããªãŠã ãšãã©ãŒããªã©ã®ã¢ã«ã³ã©ãŒãã
ããªãšãã«ã¢ãã³ãããªãžã³ãïŒïŒ®âãžã¡ãã«
ã¢ããªã³ãªã©ã®ææ©å¡©åºãæããããã該åå¿ã¯
溶åªã®ååšäžã«æå©ã«å®æœã§ãã溶åªãšããŠã¯å
å¿ã«æªåœ±é¿ãäžããªãäžæŽ»æ§ã®ãã®ããã¹ãŠçšã
ãããããšãã°ã¡ã¿ããŒã«ããšã¿ããŒã«ãããã
ããŒã«ããã¿ããŒã«ããšãã¬ã³ã°ãªã³ãŒã«ãªã©ã®
ã¢ã«ã³ãŒã«é¡ããžã¡ãã«ãšãŒãã«ãããã©ããã
ãã©ã³ããžãªããµã³ãã¢ãã°ã©ã€ã ããžã°ã©ã€ã
ãªã©ã®ãšãŒãã«é¡ãã¢ã»ãã³ãã¡ãã«ãšãã«ã±ã
ã³ãªã©ã®ã±ãã³é¡ããã³ãŒã³ããã«ãšã³ããã·ã¬
ã³ãªã©ã®è³éŠæçåæ°ŽçŽ é¡ãé ¢é žã¡ãã«ãé ¢é žãš
ãã«ãªã©ã®ãšã¹ãã«é¡ãïŒïŒ®âãžã¡ãã«ãã«ã
ã¢ããããžã¡ãã«ã¹ã«ãããµã€ãããããµã¡ãã«
ãªã³é žããªã¢ãããªã©ã®éãããã³æ§æ¥µæ§æº¶åªãª
ã©ãæããããããŸã該åå¿ã¯æ²åãããªãŠã ã
æ²åã«ãªãŠã ãªã©ã®éå±æ²åç©ã®ååšäžã«è¡ãªã
ããšãã§ãããäžèšæ¹æ³ã«ãããååç©(2)ã«å¯Ÿã
ãååç©(3)ã®äœ¿çšå²åã¯ãšãã«éå®ããããåºã
ç¯å²ã®äžããé©å®ã«éžæãããããéåžžåè ã«å¯Ÿ
ããŠåŸè ãçã¢ã«ãïŒåã¢ã«ã奜ãŸããã¯çã¢ã«
ãïŒåã¢ã«éã«ãŠçšããã®ãæãŸããããŸããã
ã®åå¿æž©åºŠãç¹ã«éå®ãããªãããéåžžã宀枩ã
200âã奜ãŸããã¯50ã160âã§è¡ãªããããåå¿
æéã¯éåžžïŒã30æéã奜ãŸããã¯ïŒã10æéã§
ãããæ¯ãããŠäžè¬åŒ(1)ã§è¡šããããååç©äžïŒ²
ãåº ã瀺ãååç©ïŒäžè¬åŒïŒ1aïŒã®ååç©ïŒãååŸ
ã§ããã äžè¬åŒ(1)ã§è¡šããããååç©äžR1åã¯R2ãåº ã瀺ãååç©ã亊ãã察å¿ããäžè¬åŒ(2)ã§è¡šãã
ããååç©åæãšããŠãåæ§ã«äžèšåå¿è¡çšåŒâ
ïŒã«åŸã補é ã§ããã ãåŒäžãR1â²ïŒR2â²ïŒR3ïŒR4ïŒR5ïŒïŒ¡ïŒïŒžåã³
ã«ã«ãã¹ããªã«éªšæ Œã®ïŒäœãšïŒäœãšã®ççŽ éçµå
ã¯åèšã«åããã äžèšåå¿è¡çšåŒâïŒã«ãããŠããããã·ã«ã«ã
ã¹ããªã«èªå°äœ(2)ãšååç©(4)ãšã®åå¿ã«ãããŠ
ã¯ãåèšåå¿è¡çšåŒâïŒã«ãããååç©(2)ãšåå
ç©(3)ãšã®åå¿ãšåæ§ã®åå¿æ¡ä»¶ãæ¡çšã§ããã ååç©(5)ãšååç©(6)ãšã®åå¿ã«ãããŠã¯ãéåžž
ã®ãšã¹ãã«ååå¿ã®æ¡ä»¶ãæ¡çšãããšãã§ããã
該åå¿ã¯ãé垞觊åªã®ååšäžã§è¡ãªããããã®é
䜿çšããã觊åªãšããŠã¯ãéåžžã®ãšã¹ãã«ååå¿
ã«äœ¿çšãããŠãããã®ãåºã䜿çšããåŸãã代衚
çãªãã®ãšããŠã¯ãäŸãã°å¡©é žã¬ã¹ãæ¿ç¡«é žããª
ã³é žãããªãªã³é žãäžåŒåç¡ŒçŽ ãéå¡©çŽ é žãªã©ã®
ç¡æ©é žãããªãããé ¢é žãããªãããã¡ã¿ã³ã¹ã«
ãã³é žãããã¿ã¬ã³ã¹ã«ãã³é žãïœâãã·ã«é žã
ãã³ãŒã³ã¹ã«ãã³é žããšã¿ã³ã¹ã«ãã³é žãªã©ã®æ
æ©é žãããªãããã¡ã¿ã³ã¹ã«ãã³é žç¡æ°Žç©ãå¡©å
ããªãã«ãã¢ã»ãã³ãžã¡ãã«ã¢ã»ã¿ãŒã«ãªã©ãäŸ
瀺ã§ãããããã«é žæ§ã€ãªã³äº€ææš¹èã該觊åªãš
ããŠçšããããšãã§ããããããã®è§Šåªã®äœ¿çšé
ã¯ç¹ã«éå®ããããéåžžã®ãšã¹ãã«ååå¿ã«çšã
ãããç¯å²ã§äœ¿çšããããäžèšåå¿ã¯ç¡æº¶åªãã
ãã¯æº¶åªäžã®ãããã§ãé²è¡ããããã®é䜿çšã
ãã溶åªãšããŠã¯ãéåžžã®ãšã¹ãã«ååå¿ã«äœ¿çš
ããã溶åªãæå¹ã«äœ¿çšã§ããå ·äœçã«ã¯ãã³ãŒ
ã³ããã«ãšã³ããã·ã¬ã³ãªã©ã®è³éŠæçåæ°ŽçŽ
é¡ããžã¯ããã¡ã¿ã³ããžã¯ãããšã¿ã³ãã¯ããã
ã«ã ãåå¡©åççŽ ãªã©ã®ããã²ã³åçåæ°ŽçŽ é¡ã
ãžãšãã«ãšãŒãã«ãããã©ããããã©ã³ããžãªã
ãµã³ããšãã¬ã³ã°ãªã³ãŒã«ã¢ãã¡ãã«ãšãŒãã«ãª
ã©ã®ãšãŒãã«é¡ãªã©ãæãããããäžèšã®åå¿ã«
ãããŠã¯ãååç©(5)ãšååç©(6)ãšã®äœ¿çšå²åã¯åº
ãç¯å²ã«ãããé©å®ã«éžæããã°ããããæ¬çºæ
ã®ç®çç©ã®çæçãè¯å¥œã«ããããã«éåžžç¡æº¶åª
ã®å Žåã«ã¯åè ã«å¯ŸãåŸè ã倧éå°éçšãããŸã
溶åªãçšããå Žåã«ã¯åè ã«å¯ŸãåŸè ãçã¢ã«ã
ïŒåã¢ã«ãç¹ã«å¥œãŸããã¯çã¢ã«ãïŒåã¢ã«éçš
ããã®ãããããªããäžèšåå¿ã®å®æœã«éããç¡
æ°Žå¡©åã«ã«ã·ãŠã ãç¡æ°Žç¡«é žé ãç¡æ°Žç¡«é žã«ã«ã·
ãŠã ãäºé žåãªã³ãªã©ã®ä¹Ÿç¥å€ãçšããŠçææ°Žã
åå¿ç³»ããé€å»ããããšã«ããããã«çæçãå¢
倧ãããããšãå¯èœã§ãããæ¬åå¿ã«æŒããåå¿
枩床ã¯é©å®éžæããã°ãããç¹ã«éå®ãããªã
ããéåžžçŽâ20ã200âçšåºŠã®ç¯å²ã§è¡ãªãã®ã
ãããç¹ã«çŽïŒã150âçšåºŠã§è¡ãªãã®ã奜ãŸã
ãããŸãåå¿æéã¯åæã®çš®é¡ãåå¿æ¡ä»¶ã«ãã
ãäžè¬ã«çŽ10åã20æéã§åå¿ã¯çµäºãããæ¯ã
ããŠäžè¬åŒïŒ1aïŒã®ååç©ãååŸãããã äžè¬åŒ(1)ã§è¡šããããååç©äžR1åã¯R2ãåº ã瀺ãååç©ã亊ã察å¿ããäžè¬åŒ(2)ã§è¡šããã
ãååç©ãåæãšããŠãåæ§ã«äžèšåå¿è¡çšåŒâ
ïŒã«åŸã補é ã§ããã ãåŒäžãR1â²ïŒR2â²ïŒR4ïŒR5ïŒïŒ¡åã³ã«ã«ãã¹
ããªã«éªšæ Œã®ïŒäœãšïŒäœãšã®ççŽ éçµåã¯åèšã«
åããã äžèšåå¿åŒã«ãããååç©(5)ãšååç©(7)ãšã®å
å¿ã¯ãé©åœãªæº¶åªäžè§Šåªã®ååšäžã«è¡ãªãããã
觊åªãšããŠã¯ãäŸãã°ããªãšãã«ã¢ãã³ãããªãž
ã³ãïŒïŒ®âãžã¡ãã«ã¢ããªã³çã®ææ©å¡©åºãé ¢
é žãããªãŠã ãçé žã«ãªãŠã çã®ç¡æ©å¡©åºçã®å¡©
åºæ§ååç©ãïœâãã«ãšã³ã¹ã«ãã³é žçã®ã¹ã«ã
ã³é žãäžåŒåç¡ŒçŽ çã®ã«ã€ã¹é žçã®é žæ§ååç©ç
ãæããããšãã§ããããŸã溶åªãšããŠã¯ãäŸã
ã°ãã³ãŒã³ããã«ãšã³ããã·ã¬ã³çã®è³éŠæçå
æ°ŽçŽ é¡ãé ¢é žã¡ãã«ãé ¢é žãšãã«çã®ãšã¹ãã«
é¡ãå¡©åã¡ãã¬ã³ãã¯ãããã«ã ãïŒïŒïŒâãžã¯
ãããšã¿ã³çã®ããã²ã³åçåæ°ŽçŽ é¡ããšãŒã
ã«ãããã©ããããã©ã³ããžãªããµã³ãã¢ãã°ã©
ã€ã ããžã°ã©ã€ã çã®ãšãŒãã«é¡ãã¢ã»ãã³ãã¡
ãã«ãšãã«ã±ãã³çã®ã±ãã³é¡ãïŒïŒ®âãžã¡ã
ã«ãã«ã ã¢ããããžã¡ãã«ã¹ã«ããã·ãããããµ
ã¡ãã«ãªã³é žããªã¢ãããâã¡ãã«ãããªãã³
çã®éãããã³æ§æ¥µæ§æº¶åªçãæããããšãã§ã
ããååç©(5)ãšååç©(7)ãšã®äœ¿çšå²åãšããŠã¯ã
éåžžåè ã«å¯ŸããŠåŸè ãå°ãªããšãçã¢ã«éçš
床ã奜ãŸããã¯ïŒãïŒåã¢ã«çšåºŠäœ¿çšããã°ã
ãããŸãäžèšè§Šåªã®äœ¿çšéãšããŠã¯ãç¹ã«éå®ã
ããªãããéåžžååç©(5)ã«å¯ŸããŠïŒïŒ100ã10å
ã¢ã«çšåºŠãšããã®ãããã該åå¿ã¯ãéåžžâ20ã
200âã奜ãŸããã¯â20ã100âçšåºŠã«ãŠãäžè¬ã«
10åã20æéçšåºŠã§çµäºããã 次ãã§åŸãããååç©(8)ãšååç©(9)ãšã®åå¿ã
亊ãé©åœãªæº¶åªäžè§Šåªã®ååšäžã«è¡ãªãããã該
溶åªãšããŠã¯ãäŸãã°ã¡ã¿ããŒã«ããšã¿ããŒã«ã
ãããããŒã«ããã¿ããŒã«ããšãã¬ã³ã°ãªã³ãŒã«
ãªã©ã®ã¢ã«ã³ãŒã«é¡ããšãŒãã«ãããã©ãããã
ã©ã³ããžãªããµã³ãã¢ãã°ã©ã€ã ããžã°ã©ã€ã ãª
ã©ã®ãšãŒãã«é¡ããã³ãŒã³ããã«ãšã³ããã·ã¬ã³
ãªã©ã®è³éŠæçåæ°ŽçŽ é¡ãå¡©åã¡ãã¬ã³ãã¯ãã
ãã«ã ãïŒïŒïŒâãžã¯ãããšã¿ã³ãªã©ã®ããã²ã³
åçåæ°ŽçŽ é¡ãïŒïŒ®âãžã¡ãã«ãã«ã ã¢ããã
ãžã¡ãã«ã¹ã«ããã·ãããããµã¡ãã«ãªã³é žããª
ã¢ãããªã©ã®éãããã³æ§æ¥µæ§æº¶åªãé ¢é žããã
ããªã³é žãªã©ã®ã«ã«ãã³é žé¡ãããªãžã³çãæã
ãããšãã§ãããŸã觊åªãšããŠã¯ãäŸãã°ããªãž
ã³ããããªãžã³ãããªãšãã«ã¢ãã³ããžãšãã«ã¢
ãã³ãDBUãªã©ã®ææ©å¡©åºããããªãŠã ãšãã©
ãŒãããããªãŠã ã¡ãã©ãŒããªã©ã®éå±ã¢ã«ã³ã©
ãŒãé¡ãæ°Žé žåãããªãŠã ãæ°Žé žåã«ãªãŠã ãç
é žã«ãªãŠã ãé ¢é žã«ãªãŠã ãªã©ã®ç¡æ©å¡©åºãå¡©
é žãç¡«é žãªã©ã®é±é žé¡ãé ¢é žãããããªã³é žãªã©
ã®ã«ã«ãã³é žé¡ãäžåŒåç¡ŒçŽ ãªã©ã®ã«ã€ã¹é žé¡ç
ãæãããããååç©(8)ãšååç©(9)ãšã®äœ¿çšå²å
ãšããŠã¯ãéåžžåè ã«å¯ŸããŠåŸè ãå°ããšãçã¢
ã«éã奜ãŸããã¯çã¢ã«ãïŒåã¢ã«çšåºŠäœ¿çšãã
ã°ããããŸã觊åªã®äœ¿çšéãšããŠã¯ãåèšååç©
(5)ãšååç©(7)ãšã®åå¿ã«ããã觊åªéãšåæ§ã«ã
ãã°ããã該åå¿ã¯ãéåžžâ20ã200âã奜ãŸã
ãã¯â20ã150âçšåºŠã«ãŠãäžè¬ã«10åã50æé
çšåºŠã§çµäºããã ååç©(10)ãšååç©(11)ãšã®åå¿ã¯ã溶åªã®ååšäž
ã«æå©ã«å®æœã§ããã溶åªãšããŠã¯åå¿ã«æªåœ±é¿
ãäžããªãäžæŽ»æ§ã®ãã®ããã¹ãŠçšããããäŸã
ã°ã¢ã»ãã³çã®ã±ãã³é¡ãã¯ãããã«ã çã®ãã
ã²ã³åçåæ°ŽçŽ é¡ãã¡ã¿ããŒã«ããšã¿ããŒã«ãã
ããããŒã«ããšãã¬ã³ã°ãªã³ãŒã«ãªã©ã®ã¢ã«ã³ãŒ
ã«é¡ããžãšãã«ãšãŒãã«ãããã©ããããã©ã³ã
ãžãªããµã³ãã¢ãã°ã©ã€ã ããžã°ã©ã€ã ãªã©ã®ãš
ãŒãã«é¡ããã³ãŒã³ããã«ãšã³ããã·ã¬ã³ãªã©ã®
è³éŠæçåæ°ŽçŽ é¡ãé ¢é žã¡ãã«ãé ¢é žãšãã«ãªã©
ã®ãšã¹ãã«é¡ãé ¢é žãããããªã³é žãªã©ã®ã«ã«ã
ã³é žãããªãžã³ãªã©ã®ææ©å¡©åºãïŒïŒ®âãžã¡ã
ã«ãã«ã ã¢ããããžã¡ãã«ã¹ã«ããã·ãããããµ
ã¡ãã«ãªã³é žããªã¢ãããªã©ã®éãããã³æ§æ¥µæ§
溶åªçãæãããããååç©(10)ãšååç©(11)ãšã®äœ¿
çšå²åã¯ãéåžžåè ã«å¯ŸãåŸè ãçã¢ã«ã10åã¢
ã«ã奜ãŸããã¯çã¢ã«ãïŒåã¢ã«çšåºŠäœ¿çšããã®
ãããã該åå¿ã¯ãéåžžâ20ã200âã奜ãŸãã
ã¯50ã150âçšåºŠã«ãŠãäžè¬ã«10åã20æéçšåºŠ
ã§çµäºãããæ¯ãããŠäžè¬åŒ(1)ã§è¡šããããåå
ç©äžïŒ²ãåº ã瀺ãäžã€R3ãã¡ãã«åºã瀺ãååç©ïŒäžè¬åŒ
ïŒ1bïŒã®ååç©ïŒãååŸã§ããã äžè¬åŒ(1)ã§è¡šããããååç©äžR1åã¯R2ãåº ã瀺ãäžã€R3ãã¡ãã«åºã瀺ãååç©ã亊ã察
å¿ããäžè¬åŒ(5)ã§è¡šããããååç©ãåæãšã
ãŠãåæ§ã«äžèšåå¿è¡çšåŒâïŒã«åŸã補é ã§ã
ãã ãåŒäžãR2â²ïŒR3ïŒR4.R5ïŒïŒ¡ïŒïŒžåã³ã«ã«ã
ã¹ããªã«éªšæ Œã®ïŒäœãšïŒäœã®ççŽ éçµåã¯åèšã«
åããR6ã¯äœçŽã¢ã«ãã«åºãäœçŽã¢ã«ã±ãã«åºã
äœçŽã¢ã«ããã«åºåã¯ïŒâããã©ããããã©ãã«
åºã瀺ããOTHPã¯ïŒâããã©ããããã©ãã«
ãªãã·åºã瀺ããã äžèšåå¿è¡çšåŒâïŒã«ããã°ãäžè¬åŒ(1)ã§è¡šã
ãããååç©äžïŒ²ãåº ã瀺ãäžã€R1ãïŒâããã©ããããã©ãã«ãªã
ã·åºã瀺ãååç©ïŒäžäžè¬åŒïŒ1cïŒã®ååç©ïŒã
å æ°Žå解ããããšã«ãã察å¿ããR1ãæ°Žé žåºã
瀺ãååç©ïŒäžè¬åŒïŒ1dïŒã®ååç©ïŒã«ãæŽã«
該ååç©ïŒ1dïŒã«ååç©(12)ãåå¿ããããšã«ã
ã察å¿ããR1ãäœçŽã¢ã«ã³ãã·åºãäœçŽã¢ã«ã±
ãã«ãªãã·åºãäœçŽã¢ã«ããã«ãªãã·åºåã¯ïŒâ
ããã©ããããã©ãã«ãªãã·åºã瀺ãååç©ïŒïŒ
è¬åŒïŒ1eïŒã®ååç©ïŒã«å€«ã å€æããããšãã§ã
ãã äžèšã«ãããŠãååç©ïŒ1cïŒã®å æ°Žå解ã¯ãç¡
溶åªåã¯é©åœãªæº¶åªäžé žãäœçšãããããšã«ãã
è¡ãããã溶åªãšããŠã¯ãäŸãã°æ°Žãã¡ã¿ããŒ
ã«ããšã¿ããŒã«ãã€ãœãããããŒã«çã®äœçŽã¢ã«
ã³ãŒã«é¡ããžãªããµã³ãããã©ããããã©ã³çã®
ãšãŒãã«é¡ãã¢ã»ãã³çã®ã±ãã³é¡ãé ¢é žåã³ã
ããã®æ··å溶åªçãæãããããé žãšããŠã¯ãäŸ
ãã°å¡©é žãç¡«é žçã®é±é žé¡ãïœâãã«ãšã³ã¹ã«ã
ã³é žãããªãžã³ïŒ°âãã«ãšã³ã¹ã«ãã³é žå¡©ãé ¢
é žãããããªã³é žçã®ã«ã«ãã³é žé¡çãæããã
ãšãã§ãããæ¯ããé žã®äœ¿çšéãšããŠã¯ãååç©
ïŒ1cïŒã«å¯ŸããŠå°ããšãçã¢ã«ä»¥äžãé垞倧éå°
é䜿çšããã®ããããåå¿æž©åºŠã¯ãéåžžâ20ã
200âã奜ãŸããã¯â20ã50âçšåºŠãšããã®ãã
ããäžè¬ã«0.5ãïŒæéçšåºŠã§åå¿ã¯çµäºããã ããããŠåŸãããååç©ïŒ1dïŒãšååç©(12)ãš
ã®åå¿ã¯ãéåžžã®ã¢ã«ãã«ååå¿ã®æ¡ä»¶äžã«è¡ãª
ãããäŸãã°å¡©åºæ§ååç©ã®ååšäžã«å®æœãã
ãããã®é䜿çšãããå¡©åºæ§ååç©ãšããŠã¯ãäŸ
ãã°éå±ãããªãŠã ãéå±ã«ãªãŠã çã®ã¢ã«ã«ãª
éå±é¡äžŠã³ã«ãããã¢ã«ã«ãªéå±ã®æ°Žé žåç©ãç
é žå¡©ãéçé žå¡©ãããã¯ã¢ã«ã³ã©ãŒãæãã¯ããª
ãžã³ããããªãžã³çã®è³éŠæã¢ãã³ååç©ãããª
ãšãã«ã¢ãã³ãïŒïŒïŒâãžã¢ã¶ãã·ã¯ããŠã³ãã»
ã³âïŒçã®ææ©å¡©åºçãæããããã該åå¿ã¯ã
é©åœãªæº¶åªäžã§æå©ã«é²è¡ãããã®é䜿çšããã
溶åªãšããŠã¯ãæ°Žãã¡ã¿ããŒã«ããšã¿ããŒã«ãã€
ãœãããããŒã«ãïœâãã¿ããŒã«çã®äœçŽã¢ã«ã³
ãŒã«é¡ãã¢ã»ãã³ãã¡ãã«ãšãã«ã±ãã³çã®ã±ã
ã³é¡ãã¯ãããã«ã ããžã¯ãããšã¿ã³çã®ããã²
ã³åçåæ°ŽçŽ é¡ããã³ãŒã³ããã«ãšã³ããã·ã¬ã³
çã®è³éŠæçåæ°ŽçŽ é¡ãïŒïŒ®âãžã¡ãã«ãã«ã
ã¢ããããžã¡ãã«ã¹ã«ããã·ãçã®éãããã³æ§
極æ§æº¶åªçãæãããããååç©ïŒ1dïŒãšåå
ç©(12)ãšã®äœ¿çšå²åãšããŠã¯ãéåžžåè ã«å¯ŸããŠåŸ
è ãå°ããšãçã¢ã«ä»¥äžã奜ãŸããã¯çã¢ã«ãïŒ
åã¢ã«éçšåºŠäœ¿çšããã®ãããã該åå¿æž©åºŠãšã
ãŠã¯ãäžè¬ã«â20ã200âã奜ãŸããã¯ïŒã100â
çšåºŠã§è¡ãªãããäžè¬ã«10åã20æéçšåºŠã§çµäº
ããã äžè¬åŒ(1)ã§è¡šããããååç©äžR2ãåº ã瀺ããR1ãæ°Žé žåºã瀺ãååç©ãR1ãäœçŽã¢
ã«ã³ãã·åºãäœçŽã¢ã«ã±ãã«ãªãã·åºãäœçŽã¢ã«
ããã«ãªãã·åºåã¯ïŒâããã©ããããã©ãã«ãª
ãã·åºã瀺ãååç©ã亊ã察å¿ããR1ãïŒâã
ãã©ããããã©ãã«ãªãã·åºã瀺ãååç©ããã
äžèšåå¿è¡çšåŒâïŒã«åŸãåæ§ã«å€æãããã åèšåå¿è¡çšåŒâïŒã«ãããŠãåºçºåæã§ãã
äžè¬åŒ(3)ã®ååç©ã¯ãäŸãã°äžèšåå¿è¡çšåŒâïŒ
ã«ç€ºãæ¹æ³ã«ãã容æã«è£œé ããããšãã§ããã ãåŒäžãR3ïŒR4ïŒR5ïŒïŒ¡åã³ïŒžã¯åèšã«å
ããã äžèšåå¿åŒã«ãããŠãååç©(9)ãšååç©ïŒ13ïŒ
ãšã®åå¿ã¯ãåèšåå¿è¡çšåŒâïŒã«ãããååç©
(8)ãšååç©(9)ãšã®åå¿ãšåæ§ã®åå¿æ¡ä»¶ãæ¡çšã§
ããã ãŸããååç©ïŒ14ïŒãšååç©(11)ãšã®åå¿ã¯ãå
èšåå¿è¡çšåŒâïŒã«ãããååç©(10)ãšååç©(11)ãš
ã®åå¿ãšåæ§ã®åå¿æ¡ä»¶ãæ¡çšã§ããã æ¯ãããŠåŸãããäžè¬åŒ(1)ã§è¡šããããååç©
ã®ãã¡å¡©åºæ§åºãæããååç©ã¯è¬ççã«èš±å®¹ã
åŸãé žãšå¡©ã圢æãåŸããæ¯ããé žãšããŠå ·äœç
ã«ã¯ç¡«é žãç¡é žãå¡©é žãèåæ°ŽçŽ é žçã®ç¡æ©é žç
ãäŸç€ºã§ããã æ¯ãããŠåŸãããæ¬çºæã®ååç©ã¯éåžžçšãã
ããŠããåé¢æ段ã«ãã容æã«åé¢ã粟補ãã
ããæ¯ããåé¢æ段ãšããŠã¯æ²æ®¿æ³ãæœåºæ³ãå
çµæ¶æ³ãã«ã©ã ã¯ãããã°ã©ãã€ãŒããã¬ãã©ã
ã€ãèå±€ã¯ãããã°ã©ãã€ãŒçãäŸç€ºã§ããã æ¬çºæååç©ã¯ãã®ãŸãŸã§ãããã¯æ £çšã®è£œå€
æ äœãšå ±ã«åç©åã³äººã«æäžããããšãã§ããã
æäžåäœåœ¢æ ãšããŠã¯ç¹ã«éå®ããªãå¿ èŠã«å¿ã
é©å®éžæããŠäœ¿çšããããæ¯ããæäžåäœåœ¢æ ãš
ããŠã¯é å€ãé¡ç²å€ãçµå£çšæº¶æ¶²çã®çµå£å€ã泚
å°å€çã®éçµå£å€çãäŸç€ºã§ãããæäžãããã¹
ãæå¹æåã®éãšããŠã¯ç¹ã«éå®ããªãåºãç¯å²
ããé©å®éžæãããããææã®å¹æãçºæ®ããã
ãã«ã¯ïŒæ¥åœãäœéïŒKgåœã0.06ã10mgãšããã®
ãããããŸãæäžåäœåœ¢æ äžã«æå¹æåãïŒã
500mgå«æããããã®ãããã æ¬çºæã«æŒãŠé å€ãã«ãã»ã«å€ãçµå£çšæº¶æ¶²ç
ã®çµå£å€ã¯åžžæ³ã«åŸã€ãŠè£œé ããããå³ã¡é å€ã¯
æ¬çºæååç©ããŒã©ãã³ã柱ç²ãä¹³ç³ãã¹ãã¢ãª
ã³é žãã°ãã·ãŠã ãæ»ç³ãã¢ã©ãã¢ãŽã çã®è£œå€
åŠç賊圢å€ãšæ··åãã賊圢ããããã«ãã»ã«å€ã¯
æ¬çºæååç©ãäžæŽ»æ§ã®è£œå€å å¡«å€ãããã¯åžé
å€ãšæ··åãã硬質ãŒã©ãã³ã«ãã»ã«ãè»è³ªã«ãã»
ã«çã«å å¡«ããããã·ãããå€ãããã¯ãšãªãã·
ã¢å€ã¯æ¬çºæååç©ãèç³çã®çå³å€ãã¡ãã«â
ããã³ãããã«ãã©ãã³é¡çã®é²è å€ãçè²å€ã
調å³å€çãšæ··åããŠè£œé ãããããŸãéçµå£å€ã¯
åžžæ³ã«åŸã€ãŠè£œé ããããå³ã¡éçµå£æäžçšè¬å€
ã¯æ¬çºæååç©ãæ» èãã液ç¶æ äœã«æº¶è§£ããŠè£œ
é ãããã奜ãŸããæ äœã¯æ°ŽãŸãã¯å¡©æ°Žã§ããã
ææã®éæ床ãå®å®æ§åã³éçµå£äœ¿çšã®é©å¿æ§ã
æãã液å€ã¯çŽïŒã500mgã®æå¹æåããæ°Žåã³
ææ©æº¶å€ã«æº¶è§£ãäžã€ååéã200ã5000ã§ãã
ããªãšãã¬ã³ã°ãªã³ãŒã«ã«æº¶è§£ããŠè£œé ãããã
æ¯ãã液å€ã«ã¯ãããªãŠã ã«ã«ããã·ã¡ãã«ã»ã«
ããŒãºãã¡ãã«ã»ã«ããŒããããªããã«ãããªã
ã³ãããªããã«ã¢ã«ã³ãŒã«çã®æœ€æ»å€ãå«æãã
ãŠããã®ã奜ãŸãããããã«ã¯äžèšæº¶å€äžã«ãã³
ãžã«ã¢ã«ã³ãŒã«ãããšããŒã«ããã¡ããµãŒã«çã®
殺èå€ããã³é²ã«ãå€ãããã«å¿ èŠã«å¿ãèç³ã
å¡©åãããªãŠã çã®ç匵å€ãå±æ麻é å€ãå®å®
å€ãç·©è¡å€çãå«ãŸããŠããŠããããæŽã«å®å®æ§
ãé«ããããã«éçµå£æäžçšè¬å€ã¯å å¡«åŸå·åã
ãããã®åéã§å ¬ç¥ã®åçµä¹Ÿç¥æè¡ã«ããæ°Žãé€
å»ããããšãã§ãããèããŠäœ¿çšçŽåã«åçµä¹Ÿç¥
ç²æ«ãå調補ããããšãã§ããã é å€ã®èª¿è£œ ããããïŒmgã®ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«â
ïŒâã¡ããã·ã«ã«ããã«âïŒâïŒïŒâãããããš
ãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ã
ãã·ããšããã·ïœã«ã«ãã¹ããªã«ãå«æããçµå£
䜿çšã®ããã®1000é ã次ã®åŠæ¹ã«ãã€ãŠèª¿è£œãã
ãã
ãè¡šã
ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·ã«
ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâ
ãžãããããªãžã³âïŒâã«ã«ããã·ããšããã·ïœ
ã«ã«ãã¹ããªã«ãä¹³ç³ãã³ãŒã³ã¹ã¿ãŒãåã³çµæ¶
ã»ã«ããŒãºãååæ··åããã¡ãã«ã»ã«ããŒãºã®ïŒ
ïŒ æ°Žæº¶æ¶²ã§é¡ç²åã200ã¡ãã·ãŠã®ç¯©ã«éããŠæ³š
ææ·±ã也ç¥ããã也ç¥ããé¡ç²ã¯200ã¡ãã·ãŠã®
篩ã«éããŠã¹ãã¢ãªã³é žãã°ãã·ãŠã ãšæ··åããŠ
é å€ã«ãã¬ã¹ãããã ã«ãã»ã«å€ã®èª¿è£œ ãããã10mgã®ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«â
ïŒâã¡ããã·ã«ã«ããã«âïŒâïŒïŒâãããããš
ãã«ïŒïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ãã
ã·ããšããã·ïœã«ã«ãã¹ããªã«ãå«æããçµå£äœ¿
çšã®ããã®1000åã®ïŒç硬質ãŒã©ãã³ã«ãã»ã«ã
次ã®åŠæ¹ã«ãã€ãŠèª¿è£œãããã
ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâ
ãžãããããªãžã³âïŒâã«ã«ããã·ããšããã·ïœ
ã«ã«ãã¹ããªã«ãä¹³ç³ãã³ãŒã³ã¹ã¿ãŒãåã³çµæ¶
ã»ã«ããŒãºãååæ··åããã¡ãã«ã»ã«ããŒãºã®ïŒ
ïŒ æ°Žæº¶æ¶²ã§é¡ç²åã200ã¡ãã·ãŠã®ç¯©ã«éããŠæ³š
ææ·±ã也ç¥ããã也ç¥ããé¡ç²ã¯200ã¡ãã·ãŠã®
篩ã«éããŠã¹ãã¢ãªã³é žãã°ãã·ãŠã ãšæ··åããŠ
é å€ã«ãã¬ã¹ãããã ã«ãã»ã«å€ã®èª¿è£œ ãããã10mgã®ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«â
ïŒâã¡ããã·ã«ã«ããã«âïŒâïŒïŒâãããããš
ãã«ïŒïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ãã
ã·ããšããã·ïœã«ã«ãã¹ããªã«ãå«æããçµå£äœ¿
çšã®ããã®1000åã®ïŒç硬質ãŒã©ãã³ã«ãã»ã«ã
次ã®åŠæ¹ã«ãã€ãŠèª¿è£œãããã
ãè¡šã
äžèšæåã现ããç²æ«ã«ããåäžãªæ··åç©ã«ãª
ãããååæ¹æããã®ã¡ææã®å¯žæ³ãæããçµå£
æäžçšã®ãŒã©ãã³ã«ãã»ã«ã«å å¡«ããã 泚å°å€ã®èª¿è£œ éçµå£æäžã«é©ãã殺èãã氎溶液ãäžèšåŠæ¹
ã«åŸã€ãŠèª¿è£œããã
ãããååæ¹æããã®ã¡ææã®å¯žæ³ãæããçµå£
æäžçšã®ãŒã©ãã³ã«ãã»ã«ã«å å¡«ããã 泚å°å€ã®èª¿è£œ éçµå£æäžã«é©ãã殺èãã氎溶液ãäžèšåŠæ¹
ã«åŸã€ãŠèª¿è£œããã
ãè¡šã
ãè¡šã
äžèšãã©ãã³é¡ãã¡ã¿éäºç¡«é
žãããªãŠã åã³
å¡©åãããªãŠã ãæ¹æããªãã80âã§äžèšã®çŽå
éã®èžçæ°Žã«æº¶è§£ãããåŸããã溶液ã40âãŸã§
å·åŽããïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ã
ãã·ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâ
ïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ããã·ãã
ãããã·ïœâïŒâããããã·âïŒïŒïŒâãžããã
ã«ã«ãã¹ããªã«åã³ããªãªãã·ãšãã¬ã³ãœã«ãã¿
ã³ã¢ããªã¬ãšãŒãããã®æº¶æ¶²äžã«æº¶è§£ããã次ã«
ãã®æº¶æ¶²ã«æ³šå°çšèžçæ°Žãå ããŠæçµã®å®¹éã«èª¿
補ããé©åœãªãã€ã«ã¿ãŒããŒããŒãçšããŠæ» è
éããããšã«ããæ» èããã ã«ãã»ã«å€ã®èª¿è£œ ãããã10mgã®ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«â
ïŒâã¡ããã·ã«ã«ããã«âïŒâïŒïŒâãããããš
ãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ã
ãã·ãããããã·ïœâïŒâããããã·âïŒïŒïŒâ
ãžãããã«ã«ãã¹ããªã«ãå«æããçµå£äœ¿çšã®ã
ãã®1000åã®ïŒç硬質ãŒã©ãã³ã«ãã»ã«ã次ã®åŠ
æ¹ã«ãã€ãŠèª¿è£œãããã
å¡©åãããªãŠã ãæ¹æããªãã80âã§äžèšã®çŽå
éã®èžçæ°Žã«æº¶è§£ãããåŸããã溶液ã40âãŸã§
å·åŽããïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ã
ãã·ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâ
ïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ããã·ãã
ãããã·ïœâïŒâããããã·âïŒïŒïŒâãžããã
ã«ã«ãã¹ããªã«åã³ããªãªãã·ãšãã¬ã³ãœã«ãã¿
ã³ã¢ããªã¬ãšãŒãããã®æº¶æ¶²äžã«æº¶è§£ããã次ã«
ãã®æº¶æ¶²ã«æ³šå°çšèžçæ°Žãå ããŠæçµã®å®¹éã«èª¿
補ããé©åœãªãã€ã«ã¿ãŒããŒããŒãçšããŠæ» è
éããããšã«ããæ» èããã ã«ãã»ã«å€ã®èª¿è£œ ãããã10mgã®ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«â
ïŒâã¡ããã·ã«ã«ããã«âïŒâïŒïŒâãããããš
ãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ã
ãã·ãããããã·ïœâïŒâããããã·âïŒïŒïŒâ
ãžãããã«ã«ãã¹ããªã«ãå«æããçµå£äœ¿çšã®ã
ãã®1000åã®ïŒç硬質ãŒã©ãã³ã«ãã»ã«ã次ã®åŠ
æ¹ã«ãã€ãŠèª¿è£œãããã
ãè¡šã
äžèšæåã现ããç²æ«ã«ããåäžãªæ··åç©ã«ãª
ããååæ¹æããã®ã¡ææã®å¯žæ³ãæããçµå£æ
äžçšã®ãŒã©ãã³ã«ãã»ã«ã«å å¡«ããã 以äžæ¬çºæååç©ã®è¬çè©Šéšçµæãæããã ïŒè¬çè©Šéš ïŒïŒ è¡å°æ¿åéæå¶äœçšãæšæçã®æ¹æ³ã«æºããŠã
ã©ãã¬ããã¢ã°ã¬ã²ãŒã·ãšã³ãã¬ãŒãµãŒ ã¢ãã«
PATâ6MïŒPlatelet Aggregation Tracer
Model PATâ6MïŒäºå ãã€ãªãµã€ãšã³ã¹ç€Ÿè£œïŒ
ãçšããŠæž¬å®ãããå»åŠã®ããã¿ã第114å·»ã第
ïŒå·ãP718ã727ãæå55幎ïŒæ30æ¥åã³
Nature927ã929ïŒ1962幎ïŒåç §ããããªãã¡ãè¡
液詊æã¯å ããæ¡åãã3.8ïŒ ã¯ãšã³é žãããªãŠ
ã 溶液ïŒãããã©ãŒããããããªåå瀟補ïŒãšå šè¡
液ã®æ··åç©ã§ãã®æ··åæ¯çã¯ïŒïŒïŒïŒå®¹éæ¯ïŒã§
ããã該詊æã1000rpmïŒ200ÃïœïŒã§10åéé å¿
åé¢ããŠãè¡å°æ¿æ¿åºŠã®é«ãè¡æž ãplatelet rich
plasmaïŒPRPïŒããåŸããåŸãããPRPãåé¢
ããæ®ãã®è¡æ¶²è©Šæã3000rpmïŒ200ÃïœïŒã§15å
éããã«é å¿åé¢ããŠè¡å°æ¿æ¿åºŠã®äœãè¡æž
ãplatelet poor plasmaïŒPPPïŒããåŸãã åèšPRPäžã«å«ãŸããŠããè¡å°æ¿ã®æ°ããã¬
ããã€ãŒã»ã¯ãã³ã«ã€ãæ³ïŒBrecher lonkite
MethodïŒã§æž¬å®ããPRPãPPPã§åžéããŠ
600000ïŒÎŒã®è¡å°æ¿ãå«ãPRPè©Šæã調補ã
ãã è©Šéšãã¹ãååç©ãäºãå®ããæ¿åºŠã§å«æãã
溶液2ÎŒã«äžèšã§èª¿è£œããPRPã®è©Šæ0.2mlãå
ããæ··åç©ã枩床37âã®æ枩槜ã«ïŒåéå ¥ããã
次ã«è©²æ··åç©ã«ADPãŸãã¯ã³ã©ãŒã²ã³æº¶æ¶²ã20ÎŒ
å ããããã®æ··åç©ã®éé床ã枬å®ããéé床
ã®å€åãæ¹æåšã®å転é床1100rpmã«ãŠåéèšã
çšããŠæž¬å®ããããã®è©Šéšã«ãããŠADP溶液ã¯
ãªãŒã¬ã³ã»ããããŒã«ç·©è¡æ¶²ïŒPH7.35ïŒãçšã
ãŠãæ¿åºŠã7.5Ã10-5Mã«ãªãããã«èª¿è£œããã
ãŸãã³ã©ãŒã²ã³æº¶æ¶²ã¯ãã³ã©ãŒã²ã³ïŒollagenã
reagent HovmïŒHovm瀟補ïŒãççé£å¡©æ°Žã§
200ÎŒïœïŒmlãšãªãããã«èª¿è£œããã è¡å°æ¿åéæå¶äœçšã¯ã³ã³ãããŒã«ã®åéçã«
察ããé»æ¢çïŒïŒ ïŒãšããŠæž¬å®ãããåéçã¯äž
åŒã«åŸãèšç®ããã åéçïŒïŒâïœïŒïœâïœÃ100 ããã§ïœïŒPRPã®éæ床 ïœïŒPPPã®éæ床 ïœïŒè©Šéšååç©åã³åéèªçºå€ãå«æã
ãPRPã®éé床 ãã®æãã³ã³ãããŒã«ã®åéçããè©Šéšåå
ç©ã®åéçããšãããšãè©Šéšååç©ã®é»æ¢ç
ïŒïŒ ïŒã¯ã以äžã®åŒã«ãã€ãŠè¡šããããã é»æ¢çïŒïŒ ïŒïŒïŒ¡âïŒïŒ¡Ã100 ã³ã©ãŒã²ã³ã§èªçºããå ã®è¡å°æ¿åéã«å¯Ÿãã
æå¶äœçšã第ïŒè¡šã«ãADPã§èªçºããå ã®è¡å°
æ¿åéã«å¯Ÿããæå¶äœçšã第ïŒè¡šã«å€«ã 瀺ãã
å°ãè©Šéšååç©ã¯ä»¥äžã®éãã§ããã äŸè©Šååç©No. ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒâããããã«ãªãã·âïŒïŒïŒâãž
ãããã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããšã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããšã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒâããããã·ïŒïŒïŒâãžãããã«
ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« 10 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããšã
ãã·ïœã«ã«ãã¹ããªã« 11 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒâããããã·âïŒïŒïŒâãžããã
ã«ã«ãã¹ããªã« 12 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒïŒïŒâããããã«ãªãã·ïŒâïŒïŒïŒ
âãžãããã«ã«ãã¹ããªã« 13 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããšã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« 14 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããšã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« 15 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«ãâïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ãã·ïœã«ã«ãã¹ããªã« 16 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« 17 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« 18 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ãã·ïœã«ã«ãã¹ããªã« 19 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžããããã¬ãžã³âïŒâã«ã«ããã·ããã
ãã·ïœâïŒâã¢ãªã«ãªãã·âïŒïŒïŒâãžããã
ã«ã«ãã¹ããªã« 20 ïŒâïœïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ãã
ã·ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâ
ïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ããã·ã
ãšããã·ïœã«ã«ãã¹ããªã« 21 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããšã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« 22 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœã«ã«ãã¹ããªã«
ããååæ¹æããã®ã¡ææã®å¯žæ³ãæããçµå£æ
äžçšã®ãŒã©ãã³ã«ãã»ã«ã«å å¡«ããã 以äžæ¬çºæååç©ã®è¬çè©Šéšçµæãæããã ïŒè¬çè©Šéš ïŒïŒ è¡å°æ¿åéæå¶äœçšãæšæçã®æ¹æ³ã«æºããŠã
ã©ãã¬ããã¢ã°ã¬ã²ãŒã·ãšã³ãã¬ãŒãµãŒ ã¢ãã«
PATâ6MïŒPlatelet Aggregation Tracer
Model PATâ6MïŒäºå ãã€ãªãµã€ãšã³ã¹ç€Ÿè£œïŒ
ãçšããŠæž¬å®ãããå»åŠã®ããã¿ã第114å·»ã第
ïŒå·ãP718ã727ãæå55幎ïŒæ30æ¥åã³
Nature927ã929ïŒ1962幎ïŒåç §ããããªãã¡ãè¡
液詊æã¯å ããæ¡åãã3.8ïŒ ã¯ãšã³é žãããªãŠ
ã 溶液ïŒãããã©ãŒããããããªåå瀟補ïŒãšå šè¡
液ã®æ··åç©ã§ãã®æ··åæ¯çã¯ïŒïŒïŒïŒå®¹éæ¯ïŒã§
ããã該詊æã1000rpmïŒ200ÃïœïŒã§10åéé å¿
åé¢ããŠãè¡å°æ¿æ¿åºŠã®é«ãè¡æž ãplatelet rich
plasmaïŒPRPïŒããåŸããåŸãããPRPãåé¢
ããæ®ãã®è¡æ¶²è©Šæã3000rpmïŒ200ÃïœïŒã§15å
éããã«é å¿åé¢ããŠè¡å°æ¿æ¿åºŠã®äœãè¡æž
ãplatelet poor plasmaïŒPPPïŒããåŸãã åèšPRPäžã«å«ãŸããŠããè¡å°æ¿ã®æ°ããã¬
ããã€ãŒã»ã¯ãã³ã«ã€ãæ³ïŒBrecher lonkite
MethodïŒã§æž¬å®ããPRPãPPPã§åžéããŠ
600000ïŒÎŒã®è¡å°æ¿ãå«ãPRPè©Šæã調補ã
ãã è©Šéšãã¹ãååç©ãäºãå®ããæ¿åºŠã§å«æãã
溶液2ÎŒã«äžèšã§èª¿è£œããPRPã®è©Šæ0.2mlãå
ããæ··åç©ã枩床37âã®æ枩槜ã«ïŒåéå ¥ããã
次ã«è©²æ··åç©ã«ADPãŸãã¯ã³ã©ãŒã²ã³æº¶æ¶²ã20ÎŒ
å ããããã®æ··åç©ã®éé床ã枬å®ããéé床
ã®å€åãæ¹æåšã®å転é床1100rpmã«ãŠåéèšã
çšããŠæž¬å®ããããã®è©Šéšã«ãããŠADP溶液ã¯
ãªãŒã¬ã³ã»ããããŒã«ç·©è¡æ¶²ïŒPH7.35ïŒãçšã
ãŠãæ¿åºŠã7.5Ã10-5Mã«ãªãããã«èª¿è£œããã
ãŸãã³ã©ãŒã²ã³æº¶æ¶²ã¯ãã³ã©ãŒã²ã³ïŒollagenã
reagent HovmïŒHovm瀟補ïŒãççé£å¡©æ°Žã§
200ÎŒïœïŒmlãšãªãããã«èª¿è£œããã è¡å°æ¿åéæå¶äœçšã¯ã³ã³ãããŒã«ã®åéçã«
察ããé»æ¢çïŒïŒ ïŒãšããŠæž¬å®ãããåéçã¯äž
åŒã«åŸãèšç®ããã åéçïŒïŒâïœïŒïœâïœÃ100 ããã§ïœïŒPRPã®éæ床 ïœïŒPPPã®éæ床 ïœïŒè©Šéšååç©åã³åéèªçºå€ãå«æã
ãPRPã®éé床 ãã®æãã³ã³ãããŒã«ã®åéçããè©Šéšåå
ç©ã®åéçããšãããšãè©Šéšååç©ã®é»æ¢ç
ïŒïŒ ïŒã¯ã以äžã®åŒã«ãã€ãŠè¡šããããã é»æ¢çïŒïŒ ïŒïŒïŒ¡âïŒïŒ¡Ã100 ã³ã©ãŒã²ã³ã§èªçºããå ã®è¡å°æ¿åéã«å¯Ÿãã
æå¶äœçšã第ïŒè¡šã«ãADPã§èªçºããå ã®è¡å°
æ¿åéã«å¯Ÿããæå¶äœçšã第ïŒè¡šã«å€«ã 瀺ãã
å°ãè©Šéšååç©ã¯ä»¥äžã®éãã§ããã äŸè©Šååç©No. ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒâããããã«ãªãã·âïŒïŒïŒâãž
ãããã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããšã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããšã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒâããããã·ïŒïŒïŒâãžãããã«
ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœã«ã«ãã¹ããªã« ïŒ ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« 10 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããšã
ãã·ïœã«ã«ãã¹ããªã« 11 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒâããããã·âïŒïŒïŒâãžããã
ã«ã«ãã¹ããªã« 12 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœâïŒïŒïŒâããããã«ãªãã·ïŒâïŒïŒïŒ
âãžãããã«ã«ãã¹ããªã« 13 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããšã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« 14 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããšã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« 15 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«ãâïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ãã·ïœã«ã«ãã¹ããªã« 16 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« 17 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« 18 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ãã·ïœã«ã«ãã¹ããªã« 19 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžããããã¬ãžã³âïŒâã«ã«ããã·ããã
ãã·ïœâïŒâã¢ãªã«ãªãã·âïŒïŒïŒâãžããã
ã«ã«ãã¹ããªã« 20 ïŒâïœïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ãã
ã·ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâ
ïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ããã·ã
ãšããã·ïœã«ã«ãã¹ããªã« 21 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããšã
ãã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããªã« 22 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·
ã«ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒ
ïŒâãžãããããªãžã³âïŒâã«ã«ããã·ããã
ããã·ïœã«ã«ãã¹ããªã«
ãè¡šã
ãè¡šã
ãè¡šã
ïŒè¬çè©Šéš ïŒïŒ
å è¡æµéåã³è¡å§ãç¢åãã®æ¹æ³ïŒæ¥è¬çèªç¬¬
57å·»380ã391é ïŒ1961ïŒåã³å¹³ãã®æ¹æ³ãClin.
exd.pharmacol.physiol.ïŒVol6ïŒ301ã316é
ïŒ1976ïŒãã«åŸã枬å®ãããããªãã¡ããã³ããã«
ãã¿ãŒã«ã®ãããªãŠã å¡©30mgïŒKgã®éèå æäžã«
ãã麻é ãè¡ã€ãäœéïŒã13Kgã®éééçš®æç¬ã
èäœã«åºå®ãã人工åŒåžäžã«ãŠéèžãè¡ãªããã
ããªã³åŠçïŒ500UïŒKgãïŒæéæ¯ã«100UïŒKgã®
è¿œå æäžïŒããåŸã以äžã®å®éšãè¡ãã ïŒ åèå æäž ã¬ã©ã¹è£œã«ããŠãŒã¬ãå³é åèããå·Šå ç¶åè
éå£éšãžæ¿å ¥ããå€§è ¿åèãšã®éã«äœå€åŸªç°è·¯ã
äœæãããå è¡æµéã¯èŠ³è¡çè¡æµãããŒããäœå€
埪ç°è·¯ã«è£ çãé»ç£è¡æµèšã«ãŠæž¬å®ãããè©Šéšå
åç©ã¯ãåããäœå€åŸªç°è·¯ã«äœæããåå²ããã
ã€ã¯ãã·ãªã³ãžãçšããŠæäžããå è¡æµéã®å¢å
éãæ±ãããåæ§ã«ã¢ããã·ã³30ÎŒïœåã¯100ÎŒïœ
ãæäžããããã®å è¡æµéå¢å éãæ±ãããã®å€
ã®å€§ããæ¹ã100ïŒ ãšããŠãè©Šéšååç©ã®å è¡æµ
éå¢å äœçšïŒïŒ ïŒãç®åºãããçµæã第ïŒè¡šã«ç€º
ãã ïŒ éèå æäž å³å¿è³ããå ç¶åèæŽãžã¢ã©ãããã«ããŠãŒã¬
ãæ¿å ¥ããæµåºããéèè¡ãå³é éèãžéæµã
ããéäžã«è£ çãã芳è¡çè¡æµãããŒãã«ããé»
ç£è¡æµèšã«ãŠè¡æµéã枬å®ãããå·Šå¿å®€åå£ã«å¿
åçž®åããã¯ã¢ãããè£ çãå¿åçž®åãããŸã倧
è ¿åèããè¡å§ããããã³ãã®èæ³¢ããå¿ææ°ã
枬å®ãããè©Šéšååç©ã¯ãå€§è ¿éèã«æ¿å ¥ããã«
ããŠãŒã¬ããæäžãããè©Šéšååç©æäžã«ããå
è¡æµéå¢å éã第ïŒè¡šã«ãåè¡å§ã®å€åéã第ïŒ
è¡šã«å€«ã 瀺ããå°ã第ïŒãïŒè¡šã«ãããŠè©Šéšåå
ç©ã¯ãåèšïŒè¬çè©ŠéšïŒïŒã«ãããäŸè©Šååç©No.
ã§ç€ºãã
57å·»380ã391é ïŒ1961ïŒåã³å¹³ãã®æ¹æ³ãClin.
exd.pharmacol.physiol.ïŒVol6ïŒ301ã316é
ïŒ1976ïŒãã«åŸã枬å®ãããããªãã¡ããã³ããã«
ãã¿ãŒã«ã®ãããªãŠã å¡©30mgïŒKgã®éèå æäžã«
ãã麻é ãè¡ã€ãäœéïŒã13Kgã®éééçš®æç¬ã
èäœã«åºå®ãã人工åŒåžäžã«ãŠéèžãè¡ãªããã
ããªã³åŠçïŒ500UïŒKgãïŒæéæ¯ã«100UïŒKgã®
è¿œå æäžïŒããåŸã以äžã®å®éšãè¡ãã ïŒ åèå æäž ã¬ã©ã¹è£œã«ããŠãŒã¬ãå³é åèããå·Šå ç¶åè
éå£éšãžæ¿å ¥ããå€§è ¿åèãšã®éã«äœå€åŸªç°è·¯ã
äœæãããå è¡æµéã¯èŠ³è¡çè¡æµãããŒããäœå€
埪ç°è·¯ã«è£ çãé»ç£è¡æµèšã«ãŠæž¬å®ãããè©Šéšå
åç©ã¯ãåããäœå€åŸªç°è·¯ã«äœæããåå²ããã
ã€ã¯ãã·ãªã³ãžãçšããŠæäžããå è¡æµéã®å¢å
éãæ±ãããåæ§ã«ã¢ããã·ã³30ÎŒïœåã¯100ÎŒïœ
ãæäžããããã®å è¡æµéå¢å éãæ±ãããã®å€
ã®å€§ããæ¹ã100ïŒ ãšããŠãè©Šéšååç©ã®å è¡æµ
éå¢å äœçšïŒïŒ ïŒãç®åºãããçµæã第ïŒè¡šã«ç€º
ãã ïŒ éèå æäž å³å¿è³ããå ç¶åèæŽãžã¢ã©ãããã«ããŠãŒã¬
ãæ¿å ¥ããæµåºããéèè¡ãå³é éèãžéæµã
ããéäžã«è£ çãã芳è¡çè¡æµãããŒãã«ããé»
ç£è¡æµèšã«ãŠè¡æµéã枬å®ãããå·Šå¿å®€åå£ã«å¿
åçž®åããã¯ã¢ãããè£ çãå¿åçž®åãããŸã倧
è ¿åèããè¡å§ããããã³ãã®èæ³¢ããå¿ææ°ã
枬å®ãããè©Šéšååç©ã¯ãå€§è ¿éèã«æ¿å ¥ããã«
ããŠãŒã¬ããæäžãããè©Šéšååç©æäžã«ããå
è¡æµéå¢å éã第ïŒè¡šã«ãåè¡å§ã®å€åéã第ïŒ
è¡šã«å€«ã 瀺ããå°ã第ïŒãïŒè¡šã«ãããŠè©Šéšåå
ç©ã¯ãåèšïŒè¬çè©ŠéšïŒïŒã«ãããäŸè©Šååç©No.
ã§ç€ºãã
ãè¡šã
ãè¡šã
ãè¡šã
åèäŸ ïŒ
æ°Žé
žåã«ãªãŠã 4.2ïœãã¡ã¿ããŒã«200mlã«æº¶è§£
ããããã«ïŒâããããã·âïŒïŒïŒâãžãããã«
ã«ãã¹ããªã«10ïœãå ãéæµäžã«ïŒâããã ãšã¿
ããŒã«10ïœã滎äžããã滎äžçµäºåŸïŒæééæµ
ããæ¿çž®åŸæ®æž£ã«æ°Žãå ããŠäžæº¶ç©ãåããã
æ°ŽæŽã¡ã¿ããŒã«ããåçµæ¶ããŠç¡è²éç¶æ¶ã®ïŒâ
ïŒïŒâããããã·ãšããã·ïŒâïŒïŒïŒâãžãããã«
ã«ãã¹ããªã«2.1ïœãåŸãã mp176ã178â äžèšãšåæ§ã«ããŠãäžèšååç©ãåŸãã ïŒâïŒïŒâããããã·ããããã·ïŒâïŒâããã
ãã«ãªãã·âïŒïŒïŒâãžãããã«ã«ãã¹ããªã« ç¡è²éç¶æ¶ïŒã¯ãããã«ã âãããµã³ïŒ mp80ã81.5â ïŒâïŒïŒâããããã·ãšããã·ïŒâïŒïŒïŒâãžãã
ãã«ã«ãã¹ããªã« ç¡è²éç¶æ¶ïŒå«æ°Žã¡ã¿ããŒã«ïŒ mp183ã155â åèäŸ ïŒ ïŒâïŒïŒâããããã·ãšããã·ïŒâïŒïŒïŒâãžã
ããã«ã«ãã¹ããªã«ïŒïœåã³ããªãšãã«ã¢ãã³ïŒ
mlã50mlã®ã¯ãããã«ã ã«å ãããžã±ãã³ïŒïœã
ããã«æ»Žäžããã宀枩ã§ïŒæ¥æ¹æåŸäžæº¶ç©ãå»
ãã液ãæ¿çž®åŸãæ®æž£ãã·ãªã«ã²ã«ã«ã©ã ã¯ã
ããïŒæº¶åºæ¶²ãã¯ãããã«ã ïŒã«ãŠç²Ÿè£œããæ¿çž®
åŸã¯ãããã«ã âãšãŒãã«ããåçµæ¶ããŠç¡è²é
ç¶æ¶ã®ïŒâïŒïŒâã¢ã»ãã¢ã»ããã·ãšããã·ïŒâ
ïŒïŒïŒâãžãããã«ã«ãã¹ããªã«1.5ïœãåŸãã mp134.5ã135.5â äžèšãšåæ§ã«ããŠïŒâïŒïŒâã¢ã»ããã·ããã
ãã·ïŒâïŒâããããã«ãªãã·âïŒïŒïŒâãžãã
ãã«ã«ãã¹ããªã«ãåŸãã ç¡è²ç²æ«ç¶æ¶ïŒã¯ãããã«ã âãããµã³ïŒ mp66ã67â åèäŸ ïŒ ãšã¿ããŒã«30mlã«ïŒâïŒïŒâã¢ã»ãã¢ã»ããã·ïŒ
âïŒïŒïŒâãžãããã«ã«ãã¹ããªã«ïŒïœåã³ïŒâ
ããããã³ãºã¢ã«ãããïŒïœãå ããå€éšæ°·å·äž
ã«ãããªãžã³0.1mlãå ããŠïŒæ¥é宀枩ã«ãŠæ¹æ
ãããæ¿çž®åŸãšãŒãã«ãå ããŠæåºç©ãåãã
ã¯ãããã«ã âãšãŒãã«ããçµæ¶ããŠïŒâïœïŒâ
ãïŒâïŒïŒâããããã³ãžãªãã³ïŒã¢ã»ãã¢ã»ãã
ã·ããšããã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããª
ã«1.3ïœãåŸããæ·¡é»è²ç²æ«ç¶æ¶ NMRïŒÎŽïŒCDCl3ïŒïŒ2.45ïŒ3HïŒïœïŒã2.46ã
2.70ïŒ2HïŒïœïŒã2.75ã3.00ïŒ2HïŒïœïŒã
4.00ã4.27ïŒ2HïŒïœïŒã4.47ã4.65ïŒ2HïŒ
ïœïŒã6.50ã6.70ïŒ3HïŒïœïŒã7.25ã7.70
ïŒ3HïŒïœïŒã7.95ã8.30ïŒ3HïŒïœïŒppm åèäŸ ïŒ ïŒâããããã³ãºã¢ã«ããã10ïœåã³ïŒâã¯ã
ããšãã«ã¢ã»ãã¢ã»ããŒã11ïœããã«ãšã³100ml
ã«æº¶è§£ããæ°·å·äžã«å¡©é žã¬ã¹ãïŒæéå¹ã蟌ãã
宀枩ã«ãŠïŒæ¥éæŸçœ®åŸæ¿çž®ããæ®æž£ãã¯ãããã«
ã æœåºããã飜åé£å¡©æ°Žã飜åéçé žãããªãŠã
ã§æŽæµåŸãç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥ãããã¯ãã
ãã«ã ãçå»ãæ®æž£ãã€ãœãããããŒã«ããåçµ
æ¶ããŠç¡è²éç¶æ¶ã®ïŒâã¯ãããšãã«ïŒâïŒïŒâ
ããããã³ãžãªãã³ïŒã¢ã»ãã¢ã»ããŒã10ïœãåŸ
ããmpã95ã97â åèäŸ ïŒ åèšåèäŸïŒãšåæ§ã«ããŠåŸãïŒâã¯ãããã
ãã«ïŒâïŒïŒâããããã³ãžãªãã³ïŒã¢ã»ãã¢ã»
ããŒã25ïœåã³ã¡ãã«ïŒâã¢ããã¯ãããŒã10ïœ
ãã¡ã¿ããŒã«100mlã«å ãïŒæééæµãäžå€æŸå·
ãããæåºããæ²æ®¿ãåãã€ãœãããããŒã«ã
ãåçµæ¶ããŠé»è²ããªãºã ç¶æ¶ã®ïŒâã¯ãããã
ãã«ã¡ãã«ïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«
âïŒâïŒïŒâãããããšãã«ïŒããªãžã³âïŒïŒïŒ
âãžã«ã«ããã·ã¬ãŒã22.7ïœãåŸãã mp144ã145â å®æœäŸ ïŒ ïŒâããããã·âïŒïŒïŒâãžãããã«ã«ãã¹ã
ãªã«1.6ïœåã³çé žã«ãªãŠã 1.5ïœãDMF30mlã«å
ã80ã90âã«å ç±ããããã«ïŒâãšãŒããããã«
ã¡ãã«ïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒ
âïŒïŒâãããããšãã«ïŒããªãžã³âïŒïŒïŒâãž
ã«ã«ããã·ã¬ãŒãïŒïœã®DMF溶液30mlã滎äžã
ãã滎äžçµäºåŸïŒæéå枩床ã§æ¹æåŸæ¿çž®ãæ®æž£
ãã¯ãããã«ã æœåºããæ°Žã0.5Næ°Žé žåãããª
ãŠã 氎溶液ãïŒïŒ å¡©é žæ°Žæº¶æ¶²åã³é£œåé£å¡©æ°Žã§æŽ
æµåŸç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥ãããæ¿çž®åŸã·ãªã«
ã²ã«ã«ã©ã ã¯ãããïŒæº¶åºæ¶²ïŒã¯ãããã«ã âã¡
ã¿ããŒã«ïŒ100ïŒïŒïŒã«ãŠç²Ÿè£œãããå«æ°Žã¡ã¿ã
ãŒã«ããåçµæ¶ããŠïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«
âïŒâã¡ããã·ã«ã«ããã«âïŒâïŒïŒâãããã
ãšãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«
ããã·ãããããã·ïœâïŒïŒïŒâãžãããã«ã«ã
ã¹ããªã«2.9ïœãåŸãã é»è²æ¿ç¶æ¶ mp167ã167.5â å®æœäŸ ïŒã33 åèšå®æœäŸïŒãšåæ§ã«ããŠäžèšç¬¬ïŒè¡šã«èšèŒã®
å®æœäŸNo.ïŒã33ã®ååç©ãåŸãã
ããããã«ïŒâããããã·âïŒïŒïŒâãžãããã«
ã«ãã¹ããªã«10ïœãå ãéæµäžã«ïŒâããã ãšã¿
ããŒã«10ïœã滎äžããã滎äžçµäºåŸïŒæééæµ
ããæ¿çž®åŸæ®æž£ã«æ°Žãå ããŠäžæº¶ç©ãåããã
æ°ŽæŽã¡ã¿ããŒã«ããåçµæ¶ããŠç¡è²éç¶æ¶ã®ïŒâ
ïŒïŒâããããã·ãšããã·ïŒâïŒïŒïŒâãžãããã«
ã«ãã¹ããªã«2.1ïœãåŸãã mp176ã178â äžèšãšåæ§ã«ããŠãäžèšååç©ãåŸãã ïŒâïŒïŒâããããã·ããããã·ïŒâïŒâããã
ãã«ãªãã·âïŒïŒïŒâãžãããã«ã«ãã¹ããªã« ç¡è²éç¶æ¶ïŒã¯ãããã«ã âãããµã³ïŒ mp80ã81.5â ïŒâïŒïŒâããããã·ãšããã·ïŒâïŒïŒïŒâãžãã
ãã«ã«ãã¹ããªã« ç¡è²éç¶æ¶ïŒå«æ°Žã¡ã¿ããŒã«ïŒ mp183ã155â åèäŸ ïŒ ïŒâïŒïŒâããããã·ãšããã·ïŒâïŒïŒïŒâãžã
ããã«ã«ãã¹ããªã«ïŒïœåã³ããªãšãã«ã¢ãã³ïŒ
mlã50mlã®ã¯ãããã«ã ã«å ãããžã±ãã³ïŒïœã
ããã«æ»Žäžããã宀枩ã§ïŒæ¥æ¹æåŸäžæº¶ç©ãå»
ãã液ãæ¿çž®åŸãæ®æž£ãã·ãªã«ã²ã«ã«ã©ã ã¯ã
ããïŒæº¶åºæ¶²ãã¯ãããã«ã ïŒã«ãŠç²Ÿè£œããæ¿çž®
åŸã¯ãããã«ã âãšãŒãã«ããåçµæ¶ããŠç¡è²é
ç¶æ¶ã®ïŒâïŒïŒâã¢ã»ãã¢ã»ããã·ãšããã·ïŒâ
ïŒïŒïŒâãžãããã«ã«ãã¹ããªã«1.5ïœãåŸãã mp134.5ã135.5â äžèšãšåæ§ã«ããŠïŒâïŒïŒâã¢ã»ããã·ããã
ãã·ïŒâïŒâããããã«ãªãã·âïŒïŒïŒâãžãã
ãã«ã«ãã¹ããªã«ãåŸãã ç¡è²ç²æ«ç¶æ¶ïŒã¯ãããã«ã âãããµã³ïŒ mp66ã67â åèäŸ ïŒ ãšã¿ããŒã«30mlã«ïŒâïŒïŒâã¢ã»ãã¢ã»ããã·ïŒ
âïŒïŒïŒâãžãããã«ã«ãã¹ããªã«ïŒïœåã³ïŒâ
ããããã³ãºã¢ã«ãããïŒïœãå ããå€éšæ°·å·äž
ã«ãããªãžã³0.1mlãå ããŠïŒæ¥é宀枩ã«ãŠæ¹æ
ãããæ¿çž®åŸãšãŒãã«ãå ããŠæåºç©ãåãã
ã¯ãããã«ã âãšãŒãã«ããçµæ¶ããŠïŒâïœïŒâ
ãïŒâïŒïŒâããããã³ãžãªãã³ïŒã¢ã»ãã¢ã»ãã
ã·ããšããã·ïœâïŒïŒïŒâãžãããã«ã«ãã¹ããª
ã«1.3ïœãåŸããæ·¡é»è²ç²æ«ç¶æ¶ NMRïŒÎŽïŒCDCl3ïŒïŒ2.45ïŒ3HïŒïœïŒã2.46ã
2.70ïŒ2HïŒïœïŒã2.75ã3.00ïŒ2HïŒïœïŒã
4.00ã4.27ïŒ2HïŒïœïŒã4.47ã4.65ïŒ2HïŒ
ïœïŒã6.50ã6.70ïŒ3HïŒïœïŒã7.25ã7.70
ïŒ3HïŒïœïŒã7.95ã8.30ïŒ3HïŒïœïŒppm åèäŸ ïŒ ïŒâããããã³ãºã¢ã«ããã10ïœåã³ïŒâã¯ã
ããšãã«ã¢ã»ãã¢ã»ããŒã11ïœããã«ãšã³100ml
ã«æº¶è§£ããæ°·å·äžã«å¡©é žã¬ã¹ãïŒæéå¹ã蟌ãã
宀枩ã«ãŠïŒæ¥éæŸçœ®åŸæ¿çž®ããæ®æž£ãã¯ãããã«
ã æœåºããã飜åé£å¡©æ°Žã飜åéçé žãããªãŠã
ã§æŽæµåŸãç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥ãããã¯ãã
ãã«ã ãçå»ãæ®æž£ãã€ãœãããããŒã«ããåçµ
æ¶ããŠç¡è²éç¶æ¶ã®ïŒâã¯ãããšãã«ïŒâïŒïŒâ
ããããã³ãžãªãã³ïŒã¢ã»ãã¢ã»ããŒã10ïœãåŸ
ããmpã95ã97â åèäŸ ïŒ åèšåèäŸïŒãšåæ§ã«ããŠåŸãïŒâã¯ãããã
ãã«ïŒâïŒïŒâããããã³ãžãªãã³ïŒã¢ã»ãã¢ã»
ããŒã25ïœåã³ã¡ãã«ïŒâã¢ããã¯ãããŒã10ïœ
ãã¡ã¿ããŒã«100mlã«å ãïŒæééæµãäžå€æŸå·
ãããæåºããæ²æ®¿ãåãã€ãœãããããŒã«ã
ãåçµæ¶ããŠé»è²ããªãºã ç¶æ¶ã®ïŒâã¯ãããã
ãã«ã¡ãã«ïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«
âïŒâïŒïŒâãããããšãã«ïŒããªãžã³âïŒïŒïŒ
âãžã«ã«ããã·ã¬ãŒã22.7ïœãåŸãã mp144ã145â å®æœäŸ ïŒ ïŒâããããã·âïŒïŒïŒâãžãããã«ã«ãã¹ã
ãªã«1.6ïœåã³çé žã«ãªãŠã 1.5ïœãDMF30mlã«å
ã80ã90âã«å ç±ããããã«ïŒâãšãŒããããã«
ã¡ãã«ïŒïŒïŒâãžãããâïŒïŒïŒâãžã¡ãã«âïŒ
âïŒïŒâãããããšãã«ïŒããªãžã³âïŒïŒïŒâãž
ã«ã«ããã·ã¬ãŒãïŒïœã®DMF溶液30mlã滎äžã
ãã滎äžçµäºåŸïŒæéå枩床ã§æ¹æåŸæ¿çž®ãæ®æž£
ãã¯ãããã«ã æœåºããæ°Žã0.5Næ°Žé žåãããª
ãŠã 氎溶液ãïŒïŒ å¡©é žæ°Žæº¶æ¶²åã³é£œåé£å¡©æ°Žã§æŽ
æµåŸç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥ãããæ¿çž®åŸã·ãªã«
ã²ã«ã«ã©ã ã¯ãããïŒæº¶åºæ¶²ïŒã¯ãããã«ã âã¡
ã¿ããŒã«ïŒ100ïŒïŒïŒã«ãŠç²Ÿè£œãããå«æ°Žã¡ã¿ã
ãŒã«ããåçµæ¶ããŠïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«
âïŒâã¡ããã·ã«ã«ããã«âïŒâïŒïŒâãããã
ãšãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«
ããã·ãããããã·ïœâïŒïŒïŒâãžãããã«ã«ã
ã¹ããªã«2.9ïœãåŸãã é»è²æ¿ç¶æ¶ mp167ã167.5â å®æœäŸ ïŒã33 åèšå®æœäŸïŒãšåæ§ã«ããŠäžèšç¬¬ïŒè¡šã«èšèŒã®
å®æœäŸNo.ïŒã33ã®ååç©ãåŸãã
ãè¡šã
ãè¡šã
å°ç¬¬ïŒè¡šã«ãããŠã¯ãåº
ã¯åŽéãšããŠè¡šãããããŸãDMFã¯ãžã¡ãã«ã
ã«ã ã¢ããããââTHPã¯ïŒâããã©ãããã
ã©ãã«ãªãã·åºãæå³ããã å®æœäŸ 34 ïŒâïŒïŒâããããã·ãšãã«ïŒâïŒïŒïŒâãžãã
ãã«ã«ãã¹ããªã«2.0ïœãïŒâã¡ããã·ã«ã«ãã
ã«âïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšã
ã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ãã³
é ž3.3ïœåã³ãžã·ã¯ãããã·ã«ã«ã«ããžã€ãã2.1
ïœãDMF50mlã«å ã80ã90âã«ïŒæéå ç±ããã
å·åŸãæ²æ®¿ãå»ãæ¿çž®åŸæ®æž£ãã¯ãããã«ã æœ
åºããã1Nâæ°Žé žåãããªãŠã åã³é£œåé£å¡©æ°Ž
ã§æŽæµåŸç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥æ¿çž®åŸãã·ãªã«
ã²ã«ã«ã©ã ã¯ãããïŒæº¶åºæ¶²ã50ïŒïŒ ã¯ããã
ã«ã âã¡ã¿ããŒã«ïŒã§ç²Ÿè£œãã¯ãããã«ã âã€ãœ
ãããã«ãšãŒãã«ããåçµæ¶ããŠé»è²ç²æ«ç¶æ¶ã®
ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·ã«ã«
ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâãž
ãããããªãžã³âïŒâã«ã«ããã·ããšããã·ïœ
ïŒïŒïŒâãžãããã«ã«ãã¹ããªã«0.5ïœãåŸãã mp262ã263.5â å®æœäŸ 35 åèšå®æœäŸ34ãšåæ§ã«ããŠãåèšå®æœäŸNo.ïŒïŒ
ïŒãïŒïŒ11ã14ïŒ16.24ïŒ26ã29ïŒ32åã³33ã®å
åç©ãåŸãã å®æœäŸ 36 ïŒâïœïŒâãïŒâïŒïŒâããããã³ãžãªãã³ïŒã¢
ã»ãã¢ã»ããã·ããšããã·ïœâïŒïŒïŒâãžããã
ã«ã«ãã¹ããªã«1.3ïœåã³ã¡ãã« ïŒâã¢ããã¯
ããããŒã0.5ïœãããªãžã³10mlã«å ãïŒæéé
æµãããæ¿çž®åŸæ®æž£ãã¯ãããã«ã ã§æœåºã飜å
ç¡«é žæ°ŽçŽ ã«ãªãŠã åã³é£œåé£å¡©æ°Žã§æŽæµãç¡«é žã
ã°ãã·ãŠã ã§ä¹Ÿç¥åŸæ¿çž®ãããæ®æž£ãã·ãªã«ã²ã«
ã«ã©ã ã¯ãããïŒæº¶åºæ¶²ïŒã¯ãããã«ã âã¡ã¿ã
ãŒã«ïŒ100ïŒïŒïŒã«ãŠç²Ÿè£œåŸãã¯ãããã«ã âãš
ãŒãã«ããåçµæ¶ããŠïŒâïœïŒâãïŒïŒïŒâãžã¡ã
ã«âïŒâã¡ããã·ã«ã«ããã«âïŒâïŒïŒâããã
ããšãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒâã«
ã«ããã·ããšããã·ïœâïŒïŒïŒâãžãããã«ã«ã
ã¹ããªã«0.92ïœãåŸãã æ·¡é»è²ç²æ«ç¶æ¶ mp172.5ã174â å®æœäŸ 37 åèšå®æœäŸ36ãšåæ§ã«ããŠãåèšå®æœäŸNo.24å
ã³25ã®ååç©ãåŸãã å®æœäŸ 38 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·ã«
ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâ
ãžãããããªãžã³âïŒâã«ã«ããã·ããããã
ã·ïœâïŒâïŒïŒâããã©ããããã©ããã·ïŒâïŒïŒ
ïŒâãžãããã«ã«ãã¹ããªã«15ïœãããã©ããã
ãã©ã³100mlãæ°Ž30mlã®æ··å液ã«å ã10ïŒ å¡©é žïŒ
mlãå ããŠå®€æž©ã§äžå€æ¹æãããæ¿çž®åŸã¯ããã
ã«ã æœåºã飜åé£å¡©æ°Žåã³é£œåéæ¹æ°Žã§æŽæµåŸç¡
æ°Žç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥åŸæ¿çž®ãããæ®æž£ã«ãš
ãŒãã«ãå ãäžæº¶ç©ãåããå«æ°Žã¡ã¿ããŒã«ã
ãåçµæ¶ããŠé»è²æ±ç¶æ¶ã®ïŒâïœïŒâãïŒïŒïŒâãž
ã¡ãã«âïŒâã¡ããã·ã«ã«ããã«âïŒâïŒïŒâã
ããããšãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒ
âã«ã«ããã·ãããããã·ïœâïŒâããããã·â
ïŒïŒïŒâãžãããã«ã«ãã¹ããªã«8.9ïœãåŸãã mp193.5ã194â å®æœäŸ 39 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·ã«
ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâ
ãžãããããªãžã³âïŒâã«ã«ããã·ããããã
ã·ïœâïŒâããããã·âïŒïŒïŒâãžãããã«ã«ã
ã¹ããªã«2.7ïœãçé žã«ãªãŠã 0.7ïœåã³èåãã
ãã«0.74ïœãã¢ã»ãã³30mlã«å ãïŒæééæµã
ããæ¿çž®åŸæ®æž£ãã¯ãããã«ã æœåºã1Nâæ°Žé ž
åãããªãŠã 氎溶液ãšæ¯ããçæããæ²æ®¿ãå»
ãããææ©å±€ã飜åé£å¡©æ°Žã§æŽæµåŸç¡«é žãã°ãã·
ãŠã ã§ä¹Ÿç¥ãããæ¿çž®åŸæ®æž£ãã·ãªã«ã²ã«ã«ã©ã
ã¯ãããïŒæº¶åºæ¶²ïŒã¯ãããã«ã âã¡ã¿ããŒã«ïŒ
100ïŒïŒïŒã«ãŠç²Ÿè£œããæ¿çž®åŸæ®æž£ãã¡ã¿ããŒã«
ããåçµæ¶ããŠïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒ
âã¡ããã·ã«ã«ããã«âïŒâïŒïŒâãããããšã
ã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ãã
ã·ãããããã·ïœâïŒâããããã·âïŒïŒïŒâãž
ãããã«ã«ãã¹ããªã«0.8ïœãåŸãã æ·¡é»è²ããªãºã ç¶æ¶ mp150.5ã152.0â å®æœäŸ 40 å®æœäŸ39ãšåæ§ã«ããŠãåèšå®æœäŸNo.ïŒïŒïŒïŒ
15åã³24ã®ååç©ãåŸãã
ã«ã ã¢ããããââTHPã¯ïŒâããã©ãããã
ã©ãã«ãªãã·åºãæå³ããã å®æœäŸ 34 ïŒâïŒïŒâããããã·ãšãã«ïŒâïŒïŒïŒâãžãã
ãã«ã«ãã¹ããªã«2.0ïœãïŒâã¡ããã·ã«ã«ãã
ã«âïŒïŒïŒâãžã¡ãã«âïŒâïŒïŒâãããããšã
ã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ãã³
é ž3.3ïœåã³ãžã·ã¯ãããã·ã«ã«ã«ããžã€ãã2.1
ïœãDMF50mlã«å ã80ã90âã«ïŒæéå ç±ããã
å·åŸãæ²æ®¿ãå»ãæ¿çž®åŸæ®æž£ãã¯ãããã«ã æœ
åºããã1Nâæ°Žé žåãããªãŠã åã³é£œåé£å¡©æ°Ž
ã§æŽæµåŸç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥æ¿çž®åŸãã·ãªã«
ã²ã«ã«ã©ã ã¯ãããïŒæº¶åºæ¶²ã50ïŒïŒ ã¯ããã
ã«ã âã¡ã¿ããŒã«ïŒã§ç²Ÿè£œãã¯ãããã«ã âã€ãœ
ãããã«ãšãŒãã«ããåçµæ¶ããŠé»è²ç²æ«ç¶æ¶ã®
ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·ã«ã«
ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâãž
ãããããªãžã³âïŒâã«ã«ããã·ããšããã·ïœ
ïŒïŒïŒâãžãããã«ã«ãã¹ããªã«0.5ïœãåŸãã mp262ã263.5â å®æœäŸ 35 åèšå®æœäŸ34ãšåæ§ã«ããŠãåèšå®æœäŸNo.ïŒïŒ
ïŒãïŒïŒ11ã14ïŒ16.24ïŒ26ã29ïŒ32åã³33ã®å
åç©ãåŸãã å®æœäŸ 36 ïŒâïœïŒâãïŒâïŒïŒâããããã³ãžãªãã³ïŒã¢
ã»ãã¢ã»ããã·ããšããã·ïœâïŒïŒïŒâãžããã
ã«ã«ãã¹ããªã«1.3ïœåã³ã¡ãã« ïŒâã¢ããã¯
ããããŒã0.5ïœãããªãžã³10mlã«å ãïŒæéé
æµãããæ¿çž®åŸæ®æž£ãã¯ãããã«ã ã§æœåºã飜å
ç¡«é žæ°ŽçŽ ã«ãªãŠã åã³é£œåé£å¡©æ°Žã§æŽæµãç¡«é žã
ã°ãã·ãŠã ã§ä¹Ÿç¥åŸæ¿çž®ãããæ®æž£ãã·ãªã«ã²ã«
ã«ã©ã ã¯ãããïŒæº¶åºæ¶²ïŒã¯ãããã«ã âã¡ã¿ã
ãŒã«ïŒ100ïŒïŒïŒã«ãŠç²Ÿè£œåŸãã¯ãããã«ã âãš
ãŒãã«ããåçµæ¶ããŠïŒâïœïŒâãïŒïŒïŒâãžã¡ã
ã«âïŒâã¡ããã·ã«ã«ããã«âïŒâïŒïŒâããã
ããšãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒâã«
ã«ããã·ããšããã·ïœâïŒïŒïŒâãžãããã«ã«ã
ã¹ããªã«0.92ïœãåŸãã æ·¡é»è²ç²æ«ç¶æ¶ mp172.5ã174â å®æœäŸ 37 åèšå®æœäŸ36ãšåæ§ã«ããŠãåèšå®æœäŸNo.24å
ã³25ã®ååç©ãåŸãã å®æœäŸ 38 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·ã«
ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâ
ãžãããããªãžã³âïŒâã«ã«ããã·ããããã
ã·ïœâïŒâïŒïŒâããã©ããããã©ããã·ïŒâïŒïŒ
ïŒâãžãããã«ã«ãã¹ããªã«15ïœãããã©ããã
ãã©ã³100mlãæ°Ž30mlã®æ··å液ã«å ã10ïŒ å¡©é žïŒ
mlãå ããŠå®€æž©ã§äžå€æ¹æãããæ¿çž®åŸã¯ããã
ã«ã æœåºã飜åé£å¡©æ°Žåã³é£œåéæ¹æ°Žã§æŽæµåŸç¡
æ°Žç¡«é žãã°ãã·ãŠã ã§ä¹Ÿç¥åŸæ¿çž®ãããæ®æž£ã«ãš
ãŒãã«ãå ãäžæº¶ç©ãåããå«æ°Žã¡ã¿ããŒã«ã
ãåçµæ¶ããŠé»è²æ±ç¶æ¶ã®ïŒâïœïŒâãïŒïŒïŒâãž
ã¡ãã«âïŒâã¡ããã·ã«ã«ããã«âïŒâïŒïŒâã
ããããšãã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒ
âã«ã«ããã·ãããããã·ïœâïŒâããããã·â
ïŒïŒïŒâãžãããã«ã«ãã¹ããªã«8.9ïœãåŸãã mp193.5ã194â å®æœäŸ 39 ïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒâã¡ããã·ã«
ã«ããã«âïŒâïŒïŒâãããããšãã«ïŒâïŒïŒïŒâ
ãžãããããªãžã³âïŒâã«ã«ããã·ããããã
ã·ïœâïŒâããããã·âïŒïŒïŒâãžãããã«ã«ã
ã¹ããªã«2.7ïœãçé žã«ãªãŠã 0.7ïœåã³èåãã
ãã«0.74ïœãã¢ã»ãã³30mlã«å ãïŒæééæµã
ããæ¿çž®åŸæ®æž£ãã¯ãããã«ã æœåºã1Nâæ°Žé ž
åãããªãŠã 氎溶液ãšæ¯ããçæããæ²æ®¿ãå»
ãããææ©å±€ã飜åé£å¡©æ°Žã§æŽæµåŸç¡«é žãã°ãã·
ãŠã ã§ä¹Ÿç¥ãããæ¿çž®åŸæ®æž£ãã·ãªã«ã²ã«ã«ã©ã
ã¯ãããïŒæº¶åºæ¶²ïŒã¯ãããã«ã âã¡ã¿ããŒã«ïŒ
100ïŒïŒïŒã«ãŠç²Ÿè£œããæ¿çž®åŸæ®æž£ãã¡ã¿ããŒã«
ããåçµæ¶ããŠïŒâïœïŒâãïŒïŒïŒâãžã¡ãã«âïŒ
âã¡ããã·ã«ã«ããã«âïŒâïŒïŒâãããããšã
ã«ïŒâïŒïŒïŒâãžãããããªãžã³âïŒâã«ã«ãã
ã·ãããããã·ïœâïŒâããããã·âïŒïŒïŒâãž
ãããã«ã«ãã¹ããªã«0.8ïœãåŸãã æ·¡é»è²ããªãºã ç¶æ¶ mp150.5ã152.0â å®æœäŸ 40 å®æœäŸ39ãšåæ§ã«ããŠãåèšå®æœäŸNo.ïŒïŒïŒïŒ
15åã³24ã®ååç©ãåŸãã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äžè¬åŒ ãåŒäžïŒ²ã¯æ°ŽçŽ åååã¯äžèšåº ã瀺ããäžèšåºã«ãããŠR3ïŒR4åã³R5ã¯äœçŽã¢
ã«ãã¬ã³åºããã¯äœçŽã¢ã«ãã¬ã³åºã瀺ãã
R1ã¯æ°ŽçŽ ååãæ°Žé žåºãäœçŽã¢ã«ã³ãã·åºãäœ
çŽã¢ã«ã±ãã«ãªãã·åºãäœçŽã¢ã«ããã«ãªãã·
åºãïŒâããã©ããããã©ãã«ãªãã·åºåã¯äžèš
åº ïŒåºäžR3ïŒR4ïŒR5åã³ïŒ¡ã¯åèšã«åãïŒã瀺
ããR2ã¯æ°ŽçŽ ååãäœçŽã¢ã«ãã«åºåã¯äžèšåº ïŒåºäžR3ïŒR4ïŒR5åã³ïŒ¡ã¯åèšã«åãïŒã瀺
ããäœãïŒR1åã³R2ã®ãã¡å¿ ããäžã€ã®ã¿ã
äžèšåº ã瀺ããã®ãšãããã«ã«ãã¹ããªã«éªšæ Œã®ïŒäœå
ã³ïŒäœã®ççŽ éçµåã¯äžéçµååã¯äºéçµåã瀺
ããã ã§è¡šããããã«ã«ãã¹ããªã«èªå°äœã
Priority Applications (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15409082A JPS5962585A (ja) | 1982-09-03 | 1982-09-03 | ã«ã«ãã¹ããªã«èªå°äœ |
| CH4807/83A CH655110A5 (de) | 1982-09-03 | 1983-09-01 | Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten. |
| KR1019830004144A KR910000181B1 (ko) | 1982-09-03 | 1983-09-02 | 칎륎볎ì€í°ëŠŽ ì ë첎ì ì ì¡°ë°©ë² |
| NL8303066A NL8303066A (nl) | 1982-09-03 | 1983-09-02 | Carbostyrilderivaten, alsmede zouten daarvan, werkwijzen ter bereiding daarvan en farmaceutische preparaten, die deze derivaten bevatten. |
| US06/528,887 US4564619A (en) | 1982-09-03 | 1983-09-02 | Carbostyril derivative |
| CA000435962A CA1252469A (en) | 1982-09-03 | 1983-09-02 | Carbostyril derivative |
| GB08323542A GB2127402B (en) | 1982-09-03 | 1983-09-02 | Pharmaceutically active carbostyril derivatives |
| DE19833331808 DE3331808A1 (de) | 1982-09-03 | 1983-09-02 | Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten |
| FR8314115A FR2532648B1 (fr) | 1982-09-03 | 1983-09-02 | Derives de carbostyrile, leur procede de preparation et leur application en therapeutique |
| ES525346A ES8502686A1 (es) | 1982-09-03 | 1983-09-02 | Un derivado de carbostirilo. |
| SE8304737A SE455503B (sv) | 1982-09-03 | 1983-09-02 | Karbostyrilderivat och framstellning och farmaceutisk kompostion derav |
| IT67922/83A IT1193145B (it) | 1982-09-03 | 1983-09-05 | Derivato del carbostirile procedimento per la sua preparazione e composizione farmaceutica contenente tale derivato |
| ES532537A ES532537A0 (es) | 1982-09-03 | 1984-05-16 | Un procedimiento para preparar un derivado de carbostirilo |
| ES532538A ES8506697A1 (es) | 1982-09-03 | 1984-05-16 | Un procedimiento para preparar un derivado de carbostirilo |
| ES532536A ES532536A0 (es) | 1982-09-03 | 1984-05-16 | Un procedimiento para preparar un derivado de carbostirilo |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15409082A JPS5962585A (ja) | 1982-09-03 | 1982-09-03 | ã«ã«ãã¹ããªã«èªå°äœ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5962585A JPS5962585A (ja) | 1984-04-10 |
| JPH0318634B2 true JPH0318634B2 (ja) | 1991-03-13 |
Family
ID=15576675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15409082A Granted JPS5962585A (ja) | 1982-09-03 | 1982-09-03 | ã«ã«ãã¹ããªã«èªå°äœ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5962585A (ja) |
-
1982
- 1982-09-03 JP JP15409082A patent/JPS5962585A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5962585A (ja) | 1984-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910000181B1 (ko) | 칎륎볎ì€í°ëŠŽ ì ë첎ì ì ì¡°ë°©ë² | |
| KR0138529B1 (ko) | 칎륎볎ì€í°ëŠŽ ì ë첎 | |
| US4952689A (en) | 3-(substituted propylidene)-2-azetidinone derivates for blood platelet aggregation | |
| JPH0378390B2 (ja) | ||
| PT98292A (pt) | Processo para a preparacao de heterociclos tioxo e de composicoes farmaceuticas que os contem | |
| US4879301A (en) | Antiallergic and antiinflammatory benzothiazolinone derivatives | |
| DK158788B (da) | Analogifremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater | |
| EP0116769B1 (en) | Dihydropyridines | |
| JPS6025423B2 (ja) | ïŒïŒïŒâãžãããããªãžã³ã®è£œæ³ | |
| SK116494A3 (en) | Bis-arylcarbinol derivatives, pharmaceutical preparations and their use | |
| JPS64397B2 (ja) | ||
| EP0093945B1 (en) | 1,4-dihydropyridine derivatives | |
| JPH03106875A (ja) | ïŒâïŒïŒâããªãžã«ã¡ãã«ïŒãã¿ã©ãžã³èªå°äœ | |
| JPS6254308B2 (ja) | ||
| US5310750A (en) | Heterocyclic compounds useful as α2 -adrenoceptor antagonists | |
| JPH0480884B2 (ja) | ||
| JPH0318636B2 (ja) | ||
| JPH068252B2 (ja) | éå§å€ | |
| JPS6113470B2 (ja) | ||
| JPH0156067B2 (ja) | ||
| JP3048698B2 (ja) | ã¢ããžãåºçœ®æè³éŠæååç©åã³ãã®å¡© | |
| US4757080A (en) | 1,4-dihydropyridine derivatives | |
| US5047543A (en) | 1,4-dihydropyridine derivatives | |
| JP3272808B2 (ja) | æ°èŠåç°ç³»ååç© | |
| US4746663A (en) | Pyrazolo[4,3-d]pyrimidine derivative, process for its production, and antihyperlipidemic or antiatherosclerotic agent containing it |